Corteva (CTVA) 10-Q 7 Nov 24 2024 Q3 Quarterly report Financial data

DEI Document

DEI Document - shares	9 Months Ended
	Sep. 30, 2024	Oct. 31, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Amendment Flag	false
Document Transition Report	false
Entity File Number	001-38710
Entity Registrant Name	Corteva, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4979096
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		687,293,000
Entity Central Index Key	0001755672
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Current Reporting Status	Yes
Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CTVA
Security Exchange Name	NYSE
EIDP
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Amendment Flag	false
Document Transition Report	false
Entity File Number	1-815
Entity Registrant Name	EIDP, Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		200
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Current Reporting Status	Yes
EIDP | Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
EIDP | $3.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$3.50 Series Preferred Stock
Trading Symbol	CTAPrA
Security Exchange Name	NYSE
EIDP | $4.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$4.50 Series Preferred Stock
Trading Symbol	CTAPrB
Security Exchange Name	NYSE

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Sales	$ 2,326	$ 2,590	$ 12,930	$ 13,519
Cost of Goods Sold	1,565	1,646	7,033	7,554
Research and Development Expense	348	335	1,037	980
Selling, General and Administrative Expenses	671	670	2,461	2,441
Amortization of Intangibles	170	174	521	508
Restructuring and Related Cost, Incurred Cost	32	2	199	95
Other income - net	(107)	(149)	(319)	(354)
Interest Expense	66	58	173	171
Income from continuing operations before income taxes	(633)	(444)	1,187	1,416
Provision for (benefit from) income taxes on continuing operations	(114)	(129)	274	244
Income from continuing operations after income taxes	(519)	(315)	913	1,172
Income (loss) from discontinued operations after income taxes	(2)	(3)	45	(174)
Net income	(521)	(318)	958	998
Net income attributable to noncontrolling interests	3	3	10	10
Net income attributable to Corteva	$ (524)	$ (321)	$ 948	$ 988
Basic earnings (loss) per share of common stock from continuing operations	$ (0.76)	$ (0.45)	$ 1.30	$ 1.64
Basic earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Basic earnings (loss) per share of common stock	(0.76)	(0.45)	1.36	1.40
Diluted earnings (loss) per share of common stock from continuing operations	(0.76)	(0.45)	1.29	1.63
Diluted earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Diluted earnings (loss) per share of common stock	$ (0.76)	$ (0.45)	$ 1.35	$ 1.39
EIDP
Net Sales	$ 2,326	$ 2,590	$ 12,930	$ 13,519
Cost of Goods Sold	1,565	1,646	7,033	7,554
Research and Development Expense	348	335	1,037	980
Selling, General and Administrative Expenses	671	670	2,461	2,441
Amortization of Intangibles	170	174	521	508
Restructuring and Related Cost, Incurred Cost	32	2	199	95
Other income - net	(89)	(149)	(281)	(354)
Interest Expense	66	60	173	193
Income from continuing operations before income taxes	(615)	(446)	1,225	1,394
Provision for (benefit from) income taxes on continuing operations	(110)	(129)	283	239
Income from continuing operations after income taxes	(505)	(317)	942	1,155
Income (loss) from discontinued operations after income taxes	(2)	(3)	45	(174)
Net income	(507)	(320)	987	981
Net income attributable to noncontrolling interests	1	0	3	2
Net income attributable to Corteva	$ (508)	$ (320)	$ 984	$ 979

Consolidated Statements of Comp

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net income	$ (521)	$ (318)	$ 958	$ 998
Cumulative Translation Adjustments	424	(323)	(206)	(41)
Derivative Instruments	7	(2)	17	(154)
Unrealized Gain (Loss) on Investments	9	0	(14)	0
Total other comprehensive income (loss)	438	(324)	(209)	(195)
Comprehensive income (loss)	(83)	(642)	749	803
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	3	3	10	10
Comprehensive Income (Loss) Attributable to Corteva	(86)	(645)	739	793
Net Cash Provided by (Used in) Operating Activities, Continuing Operations			(1,871)	(2,574)
Pension Plan
Adjustments to other benefit plans	0	3	1	6
Other Benefit Plans
Adjustments to other benefit plans	(2)	(2)	(7)	(6)
EIDP
Net income	(507)	(320)	987	981
Cumulative Translation Adjustments	424	(323)	(206)	(41)
Derivative Instruments	7	(2)	17	(154)
Unrealized Gain (Loss) on Investments	9	0	(14)	0
Total other comprehensive income (loss)	438	(324)	(209)	(195)
Comprehensive income (loss)	(69)	(644)	778	786
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	1	0	3	2
Comprehensive Income (Loss) Attributable to Corteva	(70)	(644)	775	784
Net Cash Provided by (Used in) Operating Activities, Continuing Operations			(2,977)	(2,585)
EIDP | Pension Plan
Adjustments to other benefit plans	0	3	1	6
EIDP | Other Benefit Plans
Adjustments to other benefit plans	$ (2)	$ (2)	$ (7)	$ (6)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash and cash equivalents		$ 2,421	$ 2,254	$ 2,421	$ 2,254	$ 2,644
Marketable Securities		72	108	72	108	98
Accounts and notes receivable - net		6,651	6,581	6,651	6,581	5,488
Inventories		5,674	6,320	5,674	6,320	6,899
Other current assets		831	1,070	831	1,070	1,131
Total current assets		15,649	16,333	15,649	16,333	16,260
Investments in nonconsolidated affiliates		128	106	128	106	115
Property, Plant and Equipment		9,235	8,892	9,235	8,892	8,956
Less: Accumulated Depreciation		5,025	4,572	5,025	4,572	4,669
Net Property, Plant and Equipment		4,210	4,320	4,210	4,320	4,287
Goodwill		10,629	10,441	10,629	10,441	10,605
Other intangible assets		9,084	9,795	9,084	9,795	9,626
Deferred Income Taxes		564	554	564	554	584
Other assets		1,644	1,561	1,644	1,561	1,519
Total Assets		41,908	43,110	41,908	43,110	42,996
Short-term borrowings and finance lease obligations		3,741	3,609	3,741	3,609	198
Accounts payable		3,753	3,678	3,753	3,678	4,280
Income Taxes Payable		313	236	313	236	174
Deferred Revenue		429	552	429	552	3,406
Accrued and other current liabilities		2,188	2,273	2,188	2,273	2,351
Total current liabilities		10,424	10,348	10,424	10,348	10,409
Long-term Debt		1,975	2,290	1,975	2,290	2,291
Deferred income tax liabilities		496	1,070	496	1,070	899
Pension and other post employment benefits - noncurrent		2,473	2,228	2,473	2,228	2,467
Other noncurrent obligations		1,561	1,707	1,561	1,707	1,651
Total noncurrent liabilities		6,505	7,295	6,505	7,295	7,308
Common stock		7	7	7	7	7
Additional Paid in Capital		27,518	27,895	27,518	27,895	27,748
Retained earnings (accumulated deficit)		98	325	98	325	(41)
Accumulated Other Comprehensive Income (Loss), Net of Tax		(2,886)	(3,001)	(2,886)	(3,001)	(2,677)
Total stockholders' equity attributable to the company		24,737	25,226	24,737	25,226	25,037
Noncontrolling Interests		242	241	242	241	242
Total Equity		24,979	25,467	24,979	25,467	25,279
Liabilities and Equity		41,908	43,110	41,908	43,110	42,996
Net exchange gains (losses)	[1]	(97)	(102)	(234)	(242)
Hedging Program [Member]
Net exchange gains (losses)		59	2	(35)	(60)
Argentine Peso Devaluation [Member] | Hedging Program [Member]
Net exchange gains (losses)		(26)	(83)	(54)	(150)
EIDP
Cash and cash equivalents		2,421	2,254	2,421	2,254	2,644
Marketable Securities		72	108	72	108	98
Accounts and notes receivable - net		6,651	6,581	6,651	6,581	5,488
Inventories		5,674	6,320	5,674	6,320	6,899
Other current assets		831	1,070	831	1,070	1,131
Total current assets		15,649	16,333	15,649	16,333	16,260
Investments in nonconsolidated affiliates		128	106	128	106	115
Property, Plant and Equipment		9,235	8,892	9,235	8,892	8,956
Less: Accumulated Depreciation		5,025	4,572	5,025	4,572	4,669
Net Property, Plant and Equipment		4,210	4,320	4,210	4,320	4,287
Goodwill		10,629	10,441	10,629	10,441	10,605
Other intangible assets		9,084	9,795	9,084	9,795	9,626
Deferred Income Taxes		564	554	564	554	584
Other assets		3,149	1,778	3,149	1,778	1,896
Total Assets		43,413	43,327	43,413	43,327	43,373
Short-term borrowings and finance lease obligations		3,741	3,609	3,741	3,609	198
Accounts payable		3,753	3,678	3,753	3,678	4,280
Income Taxes Payable		313	236	313	236	174
Deferred Revenue		429	552	429	552	3,406
Accrued and other current liabilities		2,177	2,284	2,177	2,284	2,347
Total current liabilities		10,413	10,474	10,413	10,474	10,405
Long-term Debt		1,975	2,290	1,975	2,290	2,291
Deferred income tax liabilities		496	1,070	496	1,070	899
Pension and other post employment benefits - noncurrent		2,473	2,228	2,473	2,228	2,467
Other noncurrent obligations		1,561	1,707	1,561	1,707	1,651
Total noncurrent liabilities		6,505	7,295	6,505	7,295	7,308
Common stock		0	0	0	0	0
Additional Paid in Capital		24,417	24,323	24,417	24,323	24,349
Retained earnings (accumulated deficit)		4,722	3,995	4,722	3,995	3,747
Accumulated Other Comprehensive Income (Loss), Net of Tax		(2,886)	(3,001)	(2,886)	(3,001)	(2,677)
Total stockholders' equity attributable to the company		26,492	25,556	26,492	25,556	25,658
Noncontrolling Interests		3	2	3	2	2
Total Equity		26,495	25,558	26,495	25,558	25,660
Liabilities and Equity		43,413	43,327	43,413	43,327	43,373
EIDP | $4.50 Series Preferred Stock [Member]
Preferred Stock		169	169	169	169	169
EIDP | $3.50 Series Preferred Stock [Member]
Preferred Stock		70	70	70	70	70
Corteva [Member] | EIDP
Other assets		1,505	217	1,505	217	377
Short-term borrowings		$ 0	$ 115	$ 0	$ 115	$ 0
[1] Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
Common Stock, Shares Authorized	1,666,667,000	1,666,667,000	1,666,667,000
Common Stock, Shares, Outstanding	689,170,000	701,260,000	704,880,000
EIDP
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares Authorized	1,800,000,000	1,800,000,000	1,800,000,000
Common Stock, Shares, Outstanding	200	200	200
EIDP | $4.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
EIDP | $3.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended						9 Months Ended				12 Months Ended
	Sep. 30, 2024		Mar. 31, 2024	Sep. 30, 2023		Mar. 31, 2023	Sep. 30, 2024		Sep. 30, 2023		Dec. 31, 2023
Net income	$ (521)		$ 423	$ (318)		$ 599	$ 958		$ 998
Income (loss) from discontinued operations after income taxes	2			3			(45)		174
Depreciation and Amortization							925		899
Provision for (benefit from) deferred income tax							(422)		(268)
Net Periodic Pension and OPEB (credits) costs, net							121		105
Pension and OPEB Contributions							(123)		(123)
Net (gain) loss on sales of property, businesses, consolidated companies, and investments							(17)		(12)
Restructuring Charges							199		95
Other net loss							377		342
Accounts and notes receivable							(1,450)		(773)
Inventories							1,060		492
Accounts Payable							(518)		(1,218)
Deferred Revenue							(2,974)		(2,840)
Other Assets and Liabilities							(38)		445
Net Cash Provided by (Used in) Operating Activities, Continuing Operations							(1,871)		(2,574)
Cash Provided by (Used in) Operating Activities, Discontinued Operations							(157)		(30)
Net Cash Provided by (Used in) Operating Activities							(2,028)		(2,604)
Capital expenditures							(416)		(412)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested							2		42
Payments to Acquire Businesses, Net of Cash Acquired							0		(1,456)
Purchases of investments							(137)		(83)
Proceeds from Sale and Maturities of Investments							115		127
Proceeds from Hedge, Investing Activities							15		42
Other investing activities - net							(38)		(2)
Cash provided by (used for) investing activities							(466)		(1,773)
Net change in borrowings (less than 90 days)							1,715		2,419
Proceeds from debt							3,047		3,427
Payments on Debt							(1,529)		(1,314)
Repurchase of Common Stock							(757)		(585)
Proceeds from Exercise of Stock Options							30		28
Dividends paid to stockholders							(340)		(327)
Other financing activities							(29)		(45)
Cash provided by (used for) financing activities							2,137		3,603
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash							(45)		(68)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash							(402)		(842)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period			3,158			3,618	3,158		3,618		$ 3,618
Cash, Cash Equivalents and Restricted Cash at End of Period	2,756	[1]		2,776	[1]		2,756	[1]	2,776	[1]	3,158
Investments in and loans to nonconsolidated affiliates							(7)		(31)
EIDP
Net income	(507)		428	(320)		589	987		981
Income (loss) from discontinued operations after income taxes	2			3			(45)		174
Depreciation and Amortization							925		899
Provision for (benefit from) deferred income tax							(422)		(268)
Net Periodic Pension and OPEB (credits) costs, net							121		105
Pension and OPEB Contributions							(123)		(123)
Net (gain) loss on sales of property, businesses, consolidated companies, and investments							(17)		(12)
Restructuring Charges							199		95
Other net loss							377		342
Accounts and notes receivable							(1,450)		(773)
Inventories							1,060		492
Accounts Payable							(518)		(1,218)
Deferred Revenue							(2,974)		(2,840)
Other Assets and Liabilities							1,097		(439)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations							(2,977)		(2,585)
Cash Provided by (Used in) Operating Activities, Discontinued Operations							(157)		(30)
Net Cash Provided by (Used in) Operating Activities							(3,134)		(2,615)
Capital expenditures							(416)		(412)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested							2		42
Payments to Acquire Businesses, Net of Cash Acquired							0		(1,456)
Purchases of investments							(137)		(83)
Proceeds from Sale and Maturities of Investments							115		127
Proceeds from Hedge, Investing Activities							15		42
Other investing activities - net							(38)		(2)
Cash provided by (used for) investing activities							(466)		(1,773)
Net change in borrowings (less than 90 days)							1,715		2,419
Repayments of Related Party Debt							0		(924)
Proceeds from debt							3,047		3,427
Payments on Debt							(1,529)		(1,314)
Proceeds from Exercise of Stock Options							30		28
Other financing activities							(20)		(51)
Cash provided by (used for) financing activities							3,243		3,614
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash							(45)		(68)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash							(402)		(842)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period			$ 3,158			$ 3,618	3,158		3,618		3,618
Cash, Cash Equivalents and Restricted Cash at End of Period	$ 2,756			$ 2,776			2,756		2,776		$ 3,158
Investments in and loans to nonconsolidated affiliates							(7)		(31)
Proceeds from Related Party Debt							$ 0		$ 29
[1]See page 15 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Statement of Stockholders Equit

Statement of Stockholders Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comp (Loss) Income	Noncontrolling Interest [Member]	EIDP	EIDP Preferred Stock [Member]	EIDP Common Stock [Member]	EIDP Additional Paid-in Capital [Member]	EIDP Retained Earnings [Member]	EIDP Accumulated Other Comp (Loss) Income	EIDP Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2022	$ 25,541	$ 7	$ 27,851	$ 250	$ (2,806)	$ 239	$ 24,749	$ 239	$ 0	$ 24,284	$ 3,031	$ (2,806)	$ 1
Net income (loss)	599			595		4	589				588		(1)
Other comprehensive (loss) income	67				67		67					67
Share-based compensation	(14)		(14)				(14)			(14)
Common Dividends	(107)			(107)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	7		7				7			7
Repurchase of common stock	(252)			(252)
Other-net	(2)			1		(3)	(4)			(2)	(2)
Ending Balance at Mar. 31, 2023	$ 25,839	7	27,844	487	(2,739)	240	25,391	239	0	24,275	3,614	(2,739)	2
Common Stock, Dividends, Per Share, Declared	$ 0.15
Beginning Balance at Dec. 31, 2022	$ 25,541	7	27,851	250	(2,806)	239	24,749	239	0	24,284	3,031	(2,806)	1
Net income (loss)	998						981
Other comprehensive (loss) income	(195)				(195)		(195)
Ending Balance at Sep. 30, 2023	25,467	7	27,895	325	(3,001)	241	25,558	239	0	24,323	3,995	(3,001)	2
Beginning Balance at Mar. 31, 2023	25,839	7	27,844	487	(2,739)	240	25,391	239	0	24,275	3,614	(2,739)	2
Net income (loss)	717			714		3	712				711		(1)
Other comprehensive (loss) income	62				62		62					62
Share-based compensation	13		14	(1)			13			14	(1)
Common Dividends	(107)			(107)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	19		19				19			19
Repurchase of common stock	(81)			(81)
Other-net	(1)			1		(2)	(4)			(2)	(1)		(1)
Ending Balance at Jun. 30, 2023	$ 26,461	7	27,877	1,013	(2,677)	241	26,191	239	0	24,306	4,321	(2,677)	2
Common Stock, Dividends, Per Share, Declared	$ 0.15
Net income (loss)	$ (318)			(321)		3	(320)				(320)
Other comprehensive (loss) income	(324)				(324)		(324)					(324)
Share-based compensation	15		16	(1)			15			16	(1)
Common Dividends	(113)			(113)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	2		2				2			2
Repurchase of common stock	(252)			(252)
Other-net	(4)			(1)		(3)	(3)			(1)	(2)
Ending Balance at Sep. 30, 2023	$ 25,467	7	27,895	325	(3,001)	241	25,558	239	0	24,323	3,995	(3,001)	2
Common Stock, Dividends, Per Share, Declared	$ 0.16
Beginning Balance at Dec. 31, 2023	$ 25,279	7	27,748	(41)	(2,677)	242	25,660	239	0	24,349	3,747	(2,677)	2
Net income (loss)	423			419		4	428				426		(2)
Other comprehensive (loss) income	(333)				(333)		(333)					(333)
Share-based compensation	2		3	(1)			2			3	(1)
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings	(112)		(112)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	8		8				8			8
Repurchase of common stock	(252)		(178)	(74)
Other-net	(7)		(1)	(1)		(5)	(1)						(1)
Ending Balance at Mar. 31, 2024	$ 25,008	7	27,468	302	(3,010)	241	25,761	239	0	24,360	4,169	(3,010)	3
Common Stock, Dividends, Per Share, Declared	$ 0.16
Beginning Balance at Dec. 31, 2023	$ 25,279	7	27,748	(41)	(2,677)	242	25,660	239	0	24,349	3,747	(2,677)	2
Net income (loss)	958						987
Other comprehensive (loss) income	(209)				(209)		(209)
Ending Balance at Sep. 30, 2024	24,979	7	27,518	98	(2,886)	242	26,495	239	0	24,417	4,722	(2,886)	3
Beginning Balance at Mar. 31, 2024	25,008	7	27,468	302	(3,010)	241	25,761	239	0	24,360	4,169	(3,010)	3
Net income (loss)	1,056			1,053		3	1,066				1,066		0
Other comprehensive (loss) income	(314)				(314)		(314)					(314)
Share-based compensation	15		15				15			15
Common Dividends	(111)			(111)
Dividends, Preferred Stock											(2)
Issuance of Corteva Stock	20		20				20			20
Repurchase of common stock	(252)			(252)
Other-net	(1)		1			(2)	4			4			0
Ending Balance at Jun. 30, 2024	$ 25,421	7	27,504	992	(3,324)	242	26,550	239	0	24,399	5,233	(3,324)	3
Common Stock, Dividends, Per Share, Declared	$ 0.16
Net income (loss)	$ (521)			(524)		3	(507)				(508)		(1)
Other comprehensive (loss) income	438				438		438					438
Share-based compensation	13		13				13			13	0
Common Dividends	(117)			(117)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	2		2				2			2
Repurchase of common stock	(253)			(253)
Other-net	(4)		(1)			(3)	2			3	0		(1)
Ending Balance at Sep. 30, 2024	$ 24,979	$ 7	$ 27,518	$ 98	$ (2,886)	$ 242	$ 26,495	$ 239	$ 0	$ 24,417	$ 4,722	$ (2,886)	$ 3
Common Stock, Dividends, Per Share, Declared	$ 0.17

Statement of Stockholders' Equi

Statement of Stockholders' Equity Parentheticals (Parentheticals) - $ / shares	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Common Stock, Dividends, Per Share, Declared	$ 0.17	$ 0.16	$ 0.16	$ 0.16	$ 0.15	$ 0.15
EIDP | $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	1.125	1.125	1.125	1.125	1.125	1.125
EIDP | $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	$ 0.875	$ 0.875	$ 0.875	$ 0.875	$ 0.875	$ 0.875

Summary of Significant Accounti

Summary of Significant Accounting Policies (Notes)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2023, collectively referred to as the “2023 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. The interim Consolidated Financial Statements and other financial information included in this Form 10-Q, unless otherwise specified, have been presented to separately show the effects of discontinued operations. During the fourth quarter of 2023, the company made the decision, which was retrospectively applied, to adjust the presentation of the interim Consolidated Statement of Cash Flows to separately present the cash provided by (used for) operating activities – discontinued operations, which was previously presented within cash provided by (used for) operating activities. See Note 13 – Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information on discontinued operations activities. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 4 percent to the company's annual net sales and less than 4 percent to each of the company's annual Seed and Crop Protection segment operating EBITDA. The company remeasures net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 7 – Supplementary Information, to the Consolidated Financial Statements, in the company's 2023 Annual Report). The Argentina government has offered USD-denominated bonds to importers, the proceeds from which could be used to pay off outstanding intercompany payables. During the first quarter of 2024, the company purchased $125 million of these foreign government bonds as part of its strategy to manage its net monetary asset exposure in Argentina. Refer to the “Debt Securities” section in Note 16 - Financial Instruments, to the interim Consolidated Financial Statements, for additional information. As of September 30, 2024, a further 10 percent deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of our net monetary assets or pre-tax earnings. The company will continue to assess the implications to our operations and financial reporting.

Recent Accounting Guidance

Recent Accounting Guidance	9 Months Ended
	Sep. 30, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement. The amendments in this ASU are intended to facilitate consistency in the application of accounting guidance upon the formation of entities qualifying as joint ventures. It generally requires the use of business combinations accounting at the joint venture formation date, which would result in the contributed assets/liabilities being revalued to fair value and potentially result in the recognition of goodwill and other intangible assets on the joint venture’s financial statements. It does not alter the ongoing accounting for the joint venture’s operations. This guidance is effective for joint ventures with formation dates on or after January 1, 2025. Prospective application is required, with early adoption permitted. Retrospective application can be elected for joint ventures formed before January 1, 2025. Beginning in the third quarter of 2024, newly-formed joint ventures have applied this guidance. Accounting Guidance Issued But Not Adopted as of September 30, 2024 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance will result in the company being required to include enhanced income tax related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment’s profit or loss measure(s) that are regularly provided to the chief operating decision maker (the “CODM”) to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The company will adopt this guidance upon its effective date and will include enhanced disclosures relating to its reportable segments for all subsequent annual and interim periods.

Business Combinations and Asset

Business Combinations and Asset Acquisitions	3 Months Ended
	Sep. 30, 2024
Business Combination and Asset Acquisition [Abstract]
Business Combination Disclosure	BUSINESS COMBINATIONS On March 1, 2023 ("Acquisition Date"), Corteva completed the acquisitions of all the outstanding equity interests in Stoller Group, Inc. (“Stoller”), one of the largest independent companies in the Biologicals industry, and Quorum Vital Investment, S.L. and its affiliates (“Symborg”), an expert in microbiological technologies. The purchase price for Stoller and Symborg was $1,220 million, inclusive of a working capital adjustment, and $370 million, respectively. These acquisitions supplement the Crop Protection business with additional biological tools that complement evolving farming practices. The company finalized the purchase price allocation and assessment of the fair value of the assets acquired and liabilities assumed as of the Acquisition Date in the first quarter of 2024. There were no material adjustments recognized during the measurement period. For additional information regarding the acquisition of Stoller and Symborg, see Note 4 - Business Combinations, to the Consolidated Financial Statements, in the company's 2023 Annual Report.

Revenue (Notes)

Revenue (Notes)	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer	REVENUE Remaining Performance Obligations Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $140 million, $134 million and $135 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of one year to six years. Contract Balances Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract Balances September 30, 2024 December 31, 2023 September 30, 2023 (In millions) Accounts and notes receivable - trade 1 $ 5,501 $ 4,329 $ 5,320 Contract assets - current 2 $ 29 $ 27 $ 27 Contract assets - noncurrent 3 $ 73 $ 67 $ 67 Deferred revenue - current $ 429 $ 3,406 $ 552 Deferred revenue - noncurrent 4 $ 115 $ 108 $ 109 1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. 2. Included in other current assets in the interim Consolidated Balance Sheets. 3. Included in other assets in the interim Consolidated Balance Sheets. 4. Included in other noncurrent obligations in the interim Consolidated Balance Sheets. Revenue recognized during the nine months ended September 30, 2024 and 2023 from amounts included in deferred revenue at the beginning of the period was $3,314 million and $3,287 million, respectively. Disaggregation of Revenue Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below: Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Corn $ 315 $ 487 $ 5,085 $ 5,139 Soybean 164 189 1,773 1,713 Other oilseeds 135 142 566 637 Other 77 60 349 348 Seed 691 878 7,773 7,837 Herbicides 736 815 2,568 3,043 Insecticides 437 416 1,225 1,156 Fungicides 216 226 761 837 Other 246 255 603 646 Crop Protection 1,635 1,712 5,157 5,682 Total $ 2,326 $ 2,590 $ 12,930 $ 13,519 Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below: Seed Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 North America 1 $ 170 $ 173 $ 5,394 $ 5,192 EMEA 2 196 198 1,365 1,441 Latin America 218 380 696 847 Asia Pacific 107 127 318 357 Total $ 691 $ 878 $ 7,773 $ 7,837 Crop Protection Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 North America 1 $ 440 $ 399 $ 1,703 $ 1,901 EMEA 2 219 271 1,311 1,555 Latin America 771 844 1,458 1,537 Asia Pacific 205 198 685 689 Total $ 1,635 $ 1,712 $ 5,157 $ 5,682 1. Represents U.S. & Canada. 2. Europe, Middle East and Africa ("EMEA").

Restructuring and Asset Related

Restructuring and Asset Related Charges	9 Months Ended
	Sep. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	RESTRUCTURING AND ASSET RELATED CHARGES - NET Crop Protection Operations Strategy Restructuring Program On November 5, 2023, management of the company approved a plan to further optimize its Crop Protection network of manufacturing and external partners (the "Crop Protection Operations Strategy Restructuring Program"). In October 2024, management of the company amended the Crop Protection Operations Strategy Restructuring Program to include revisions to its previous estimates and decommissioning and demolition costs associated with the ceasing of operations, primarily at the Pittsburg, California site. The company expects to record aggregate pre-tax restructuring and asset related charges of $650 million to $700 million, comprised of $85 million to $105 million of severance and related benefit costs, $320 million to $340 million of asset-related and impairment charges and $245 million to $255 million of costs related to exiting the company’s production activities and ceasing operations (inclusive of contract terminations and decommissioning and demolition costs). Decommissioning and demolition costs will be expensed on an as-incurred basis. Reductions in workforce are subject to local regulatory requirements. Through the third quarter of 2024, the company recorded net pre-tax restructuring and asset related charges of $372 million, comprised of $60 million of severance and related benefit costs, $309 million of asset-related and impairment charges and $3 million of costs related to contract terminations. The pre-tax restructuring and asset related charges noted above includes charges relating to spare parts write-offs recognized during the fourth quarter of 2023, which impacted the Crop Protection segment, and were included in cost of goods sold, in the company’s Consolidated Statement of Operations for the year ended December 31, 2023. See Note 23 – Segment Information, to the Consolidated Financial Statements, in the company’s 2023 Annual Report for additional information. Cash payments related to these charges are anticipated to be $330 million to $360 million, which primarily relate to the payment of severance and related benefits, contract terminations and decommissioning and demolition. Through the third quarter of 2024, the company paid $10 million associated with these charges. The restructuring actions associated with these charges are expected to be substantially complete by the end of 2026. The following table is a summary of charges incurred related to the Crop Protection Operations Strategy Restructuring Program for the three and nine months ended September 30, 2024. (In millions) Three Months Ended September 30, 2024 Nine Months Ended September 30, 2024 Severance and related benefit costs 1 $ 19 $ 60 Asset related charges 2, 3 10 83 Total restructuring and asset related charges - net $ 29 $ 143 1. Reflects corporate-related charges. 2. Reflects charges associated with the Crop Protection segment. 3. The three and nine months ended September 30, 2024 include charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California. A reconciliation of the December 31, 2023 to the September 30, 2024 liability balances related to the Crop Protection Operations Strategy Restructuring Program is summarized below: (In millions) Severance and Related Benefit Costs Asset Related Charges 1 Total Balance at December 31, 2023 $ — $ — $ — Charges to income from continuing operations 60 83 143 Payments (3) (4) (7) Asset write-offs — (79) (79) Balance at September 30, 2024 $ 57 $ — $ 57 1. Includes charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California. 2022 Restructuring Actions In connection with the company’s shift to a global business unit model during 2022, the company assessed its business priorities and operational structure to maximize the customer experience and deliver on growth and earnings potential. As a result of this assessment, the company committed to restructuring actions during the second quarter of 2022, which included the company’s separate announcement to withdraw from Russia (“Russia Exit”) (collectively the “2022 Restructuring Actions”). The company does not anticipate any additional material charges from the 2022 Restructuring Actions as actions associated with this charge are substantially complete. The remaining cash payments related to these charges is $36 million, and primarily relate to the payment of severance and related benefits and contract terminations. The following table is a summary of charges incurred related to the 2022 Restructuring Actions for the three and nine months ended September 30, 2024 and 2023. Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Severance and related benefit costs 1 $ — $ — $ — $ 4 Asset related charges — — (2) 11 Contract termination charges 3 3 1 3 4 Total restructuring and asset related charges - net 2,3 $ 3 $ 1 $ 1 $ 19 1. Reflects corporate-related charges. 2. The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment. 3. This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information. Other Asset Related Charges The company recognized charges (benefits) of $55 million for the nine months ended September 30, 2024, and $(2) million and $66 million for the three and nine months ended September 30, 2023 respectively, in restructuring and asset related charges - net, in the interim Consolidated Statement of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits, which as of the end of the second quarter of 2024 is now complete.

Supplementary Information

Supplementary Information	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Additional Financial Information Disclosure [Text Block]	SUPPLEMENTARY INFORMATION Other Income (Expense) - Net Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Interest income $ 33 $ 59 $ 93 $ 153 Equity in earnings (losses) of affiliates - net — (2) 7 4 Net gain (loss) on sales of businesses and other assets — 10 17 11 Net exchange gains (losses) 1 (97) (102) (234) (242) Non-operating pension and other post employment benefit credits (costs) 2 (37) (30) (109) (91) Miscellaneous income (expenses) - net 3 (6) (84) (93) (189) Other income (expense) - net $ (107) $ (149) $ (319) $ (354) 1. Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively. 2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 3. The three and nine months ended September 30, 2024 includes tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont ("Tax Indemnification Adjustments"), while the nine months ended September 30, 2024 additionally includes the receipt of an indemnification payment negotiated with the prior Stoller owners and estimated settlement reserves. The three and nine months ended September 30, 2023 includes Tax Indemnification Adjustments and an adjustment to the Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) due to a change in estimate as well as estimated settlement reserves. The nine months ended September 30, 2023 also includes gains on the sale of assets, and a loss on the sale of the company's interest in an equity investment. The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statements of Operations. Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Subsidiary Monetary Position Gain (Loss) Pre-tax exchange gain (loss) $ (156) $ (104) $ (199) $ (182) Local tax (expenses) benefits 5 19 23 27 Net after-tax impact from subsidiary exchange gain (loss) $ (151) $ (85) $ (176) $ (155) Hedging Program Gain (Loss) Pre-tax exchange gain (loss) $ 59 $ 2 $ (35) $ (60) Tax (expenses) benefits (12) (4) 7 12 Net after-tax impact from hedging program exchange gain (loss) $ 47 $ (2) $ (28) $ (48) Total Exchange Gain (Loss) Pre-tax exchange gain (loss) $ (97) $ (102) $ (234) $ (242) Tax (expenses) benefits (7) 15 30 39 Net after-tax exchange gain (loss) $ (104) $ (87) $ (204) $ (203) Non-Controlling Interest Adjustment — — 1 — Net after-tax exchange gain (loss) attributable to Corteva $ (104) $ (87) $ (203) $ (203) Cash, cash equivalents and restricted cash equivalents The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the interim Consolidated Balance Sheets. (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Cash and cash equivalents $ 2,421 $ 2,644 $ 2,254 Restricted cash equivalents 335 514 522 Total cash, cash equivalents and restricted cash equivalents $ 2,756 $ 3,158 $ 2,776 Restricted cash equivalents is primarily comprised of a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters and the settlement of legacy PFAS matters and the associated qualified spend. During the second quarter of 2024, the previously-restricted cash in the Water District Settlement Fund, which was established by the settling companies in September 2023 under the Nationwide Water District Settlement, was released. Collective contributions amounted to $1.185 billion, with Chemours contributing 50 percent and DuPont and Corteva collectively contributing the remaining 50 percent pursuant to the terms of the Letter Agreement. All of the company's restricted cash equivalents are classified as current as of September 30, 2024, December 31, 2023 and September 30, 2023, except for the 2024 contribution to the MOU Escrow Account, which is classified as noncurrent as of September 30, 2024. At September 30, 2024, December 31, 2023 and September 30, 2023, accounts payable was $3,753 million, $4,280 million and $3,678 million, respectively, which includes accounts payable - trade of $2,051 million, $2,952 million, and $2,046 million, respectively. Included in accounts payable – trade was seed grower compensation of approximately $214 million, $560 million, and $217 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively, which is measured at fair value using Level 2 inputs for each period presented.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	INCOME TAXES The effective tax rate for the three and nine months ended September 30, 2024 was 18.0 percent and 23.1 percent, respectively, and 29.1 percent and 17.2 percent for the three and nine months ended September 30, 2023, respectively. During the three and nine months ended September 30, 2024, the company recognized $10 million and $25 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes and accruals for certain prior year tax positions in various jurisdictions as well as from stock-based compensation. During the three and nine months ended September 30, 2023, the company recognized $11 million and $79 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes, accruals for certain prior year tax positions in various jurisdictions, stock-based compensation, as well as the impact of changes to deferred taxes associated with a tax currency change for a legal entity. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information, to the interim Consolidated Financial Statements.

Earnings Per Share (Notes)

Earnings Per Share (Notes)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE OF COMMON STOCK The following tables provide earnings per share calculations for the periods indicated below: Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (519) $ (315) $ 913 $ 1,172 Net income (loss) attributable to continuing operations noncontrolling interests 3 3 10 10 Income (loss) from continuing operations available to Corteva common stockholders (522) (318) 903 1,162 Income (loss) from discontinued operations available to Corteva common stockholders (2) (3) 45 (174) Net income (loss) available to common stockholders $ (524) $ (321) $ 948 $ 988 Earnings (Loss) Per Share Calculations - Basic Three Months Ended September 30, Nine Months Ended September 30, (Dollars per share) 2024 2023 2024 2023 Earnings (loss) per share of common stock from continuing operations $ (0.76) $ (0.45) $ 1.30 $ 1.64 Earnings (loss) per share of common stock from discontinued operations — — 0.06 (0.24) Earnings (loss) per share of common stock $ (0.76) $ (0.45) $ 1.36 $ 1.40 Earnings (Loss) Per Share Calculations - Diluted Three Months Ended September 30, Nine Months Ended September 30, (Dollars per share) 2024 2023 2024 2023 Earnings (loss) per share of common stock from continuing operations $ (0.76) $ (0.45) $ 1.29 $ 1.63 Earnings (loss) per share of common stock from discontinued operations — — 0.06 (0.24) Earnings (loss) per share of common stock $ (0.76) $ (0.45) $ 1.35 $ 1.39 Share Count Information Three Months Ended September 30, Nine Months Ended September 30, (Shares in millions) 2024 2023 2024 2023 Weighted-average common shares - basic 691.1 708.4 695.8 710.7 Plus: dilutive effect of equity compensation plans 1 — — 2.5 2.9 Weighted-average common shares - diluted 691.1 708.4 698.3 713.6 Potential shares of common stock excluded from EPS calculations 2 2.5 2.2 3.4 2.4 1. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. 2. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable (

Accounts and Notes Receivable (Notes)	9 Months Ended
	Sep. 30, 2024
Accounts and Notes Receivable [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	ACCOUNTS AND NOTES RECEIVABLE - NET (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Accounts receivable – trade 1 $ 4,260 $ 4,210 $ 4,013 Notes receivable – trade 1,2 1,241 119 1,307 Other 3 1,150 1,159 1,261 Total accounts and notes receivable - net $ 6,651 $ 5,488 $ 6,581 1. Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. 2. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2024, December 31, 2023 and September 30, 2023, there were no significant impairments related to current loan agreements. 3. Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $145 million, $131 million and $137 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively. Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets. The following table summarizes changes in the allowance for doubtful receivables for the nine months ended September 30, 2024 and 2023: (In millions) 2023 Balance at December 31, 2022 $ 194 Net provision for credit losses 10 Other - net of write-offs charged against allowance (3) Balance at September 30, 2023 $ 201 2024 Balance at December 31, 2023 $ 205 Net provision for credit losses 31 Other - net of write-offs charged against allowance (48) Balance at September 30, 2024 $ 188 The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Consolidated Balance Sheets. Trade receivables sold under these agreements were $51 million and $118 million for the three and nine months ended September 30, 2024, respectively, and $57 million and $100 million for the three and nine months ended September 30, 2023, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of September 30, 2024, December 31, 2023 and September 30, 2023 were $17 million, $2 million and $19 million, respectively. The net proceeds received are included in cash provided by (used for) operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense) - net, in the interim Consolidated Statements of Operations. The loss on sale of receivables was $5 million and $8 million for the three and nine months ended September 30, 2024, respectively, and $4 million and $17 million for the three and nine months ended September 30, 2023, respectively. See Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information on the company’s guarantees.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	INVENTORIES (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Finished products $ 2,399 $ 3,273 $ 2,786 Semi-finished products 2,785 2,775 2,690 Raw materials and supplies 490 851 844 Total inventories $ 5,674 $ 6,899 $ 6,320

Other Intangible Assets

Other Intangible Assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure	OTHER INTANGIBLE ASSETS The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: September 30, 2024 December 31, 2023 September 30, 2023 (In millions) Gross Accumulated Net Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization (finite-lived): Germplasm $ 6,291 $ (1,272) $ 5,019 $ 6,291 $ (1,081) $ 5,210 $ 6,291 $ (1,017) $ 5,274 Customer-related 2,413 (844) 1,569 2,427 (734) 1,693 2,403 (688) 1,715 Developed technology 1,838 (1,126) 712 1,849 (1,004) 845 1,845 (958) 887 Trademarks/trade names 2,056 (359) 1,697 2,111 (339) 1,772 2,110 (314) 1,796 Other 1 388 (306) 82 395 (294) 101 395 (288) 107 Total other intangible assets with finite lives 12,986 (3,907) 9,079 13,073 (3,452) 9,621 13,044 (3,265) 9,779 Intangible assets not subject to amortization (indefinite-lived): In-process research & development 5 — 5 5 — 5 16 — 16 Total other intangible assets with 5 — 5 5 — 5 16 — 16 Total other intangible assets $ 12,991 $ (3,907) $ 9,084 $ 13,078 $ (3,452) $ 9,626 $ 13,060 $ (3,265) $ 9,795 1. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements. The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $170 million and $521 million for the three and nine months ended September 30, 2024, respectively, and $174 million and $508 million for the three and nine months ended September 30, 2023, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2024 and each of the next five years is approximately $164 million, $644 million, $634 million, $574 million, $552 million and $529 million, respectively.

Short-Term Borrowings, Long-Ter

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES The following tables summarize Corteva's short-term borrowings and finance lease obligations and long-term debt: Short-term borrowings and finance lease obligations (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Commercial paper $ 2,969 $ — $ 3,417 364-Day Revolving Credit Facility — — — Other loans - various currencies 271 1 3 Long-term debt payable within one year 500 196 188 Finance lease obligations payable within one year 1 1 1 Total short-term borrowings and finance lease obligations $ 3,741 $ 198 $ 3,609 Long-term debt (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2026 600 4.50 % 600 4.50 % 600 4.50 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Maturing in 2033 600 4.80 % 600 4.80 % 600 4.80 % Other loans: Foreign currency loans, various rates and maturities 184 12.70 % 196 14.80 % 188 14.80 % Medium-term notes, varying maturities through 2041 104 4.94 % 106 5.34 % 106 5.33 % Finance lease obligations — 1 1 Less: Unamortized debt discount and issuance costs 13 16 17 Less: Long-term debt due within one year 500 196 188 Total long-term debt $ 1,975 $ 2,291 $ 2,290 The estimated fair value of the company's short-term and long-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations approximated carrying value. The fair value of the company’s long-term borrowings, including debt due within one year, was $2,437 million, $2,434 million and $2,320 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively. Debt Offering In May 2023, the company issued $600 million of 4.50 percent Senior Notes due in 2026 and $600 million of 4.80 percent Senior Notes due in 2033 (the “May 2023 Debt Offering”). The proceeds of this offering were used for general corporate purposes, including funding of working capital, capital expenditures and share repurchases. Foreign Currency Loans The company enters into short-term and long-term foreign currency loans from time-to-time by accessing uncommitted revolving credit lines to fund working capital needs of foreign subsidiaries in the normal course of business (“Foreign Currency Loans”). Interest rates are variable and determined at the time of borrowing. Total unused bank credit lines on the Foreign Currency Loans at September 30, 2024 was approximately $38 million. The company’s Foreign Currency Loans have varying maturities through 2026. Available Committed Credit Facilities The following table summarizes the company's credit facilities: Committed and Available Credit Facilities at September 30, 2024 (In millions) Effective Date Committed Credit Credit Available Maturity Date Interest Revolving Credit Facility June 2024 $ 2,850 $ 2,850 June 2029 Floating Rate Revolving Credit Facility June 2024 1,900 1,900 June 2027 Floating Rate 364-Day Revolving Credit Facility February 2024 1,000 1,000 February 2025 Floating Rate Total Committed and Available Credit Facilities $ 5,750 $ 5,750 Revolving Credit Facilities In May 2022, the company entered into a $3 billion, five three plus the applicable margin. In June 2024, the Revolving Credit Facilities were refinanced for purposes of extending the maturity dates for the five-year and three-year revolving credit facilities to June 2029 and June 2027, respectively, and lowering the facility amount of the five three 364-Day Revolving Credit Facility In February 2024, the company amended and restated its July 2023 (as amended in July 2023 and January 2024) 364-day revolving credit agreement (the “364-Day Revolving Credit Facility”) increasing the facility amount to $1 billion and extending the expiration date to February 2025. Borrowings under the 364-Day Revolving Credit Facility will have an interest rate equal to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent, plus the applicable margin. The 364-Day Revolving Credit Facility includes a provision under which the company may convert any advances outstanding prior to the maturity date into term loans having a maturity date up to one year later. In February 2023, the company drew down $1 billion under the 364-Day Revolving Credit Facility, which was used for general corporate purposes, including funding seasonal working capital needs, capital spending, dividend payments, share repurchases and to partially fund the Stoller and Symborg acquisitions. In May 2023, the company repaid the $1 billion loan using the proceeds from the May 2023 Debt Offering. The 364-Day Revolving Credit Facility contains customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the 364-Day Revolving Credit Facility contains a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At September 30, 2024, the company was in compliance with these covenants.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES Guarantees Indemnifications In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement. Obligations for Supplier Finance Programs The company enters into supplier finance programs with various finance providers in which the company agrees to pay these finance providers the stated amount of confirmed invoices from participating suppliers by the original maturity date. The company or the financial provider may terminate the agreement upon providing at least thirty days’ written notice. The payment terms that the company has with its finance providers under supplier finance programs are less than one year. At September 30, 2024, December 31, 2023 and September 30, 2023, the outstanding obligations under supplier finance programs was $124 million, $115 million and $115 million, respectively, and included within accounts payable in the interim Consolidated Balance Sheets. The rollforward of the company’s outstanding obligations confirmed as valid under its supplier finance programs for the period ended September 30, 2024 is as follows: (In millions) Confirmed obligations outstanding at December 31, 2023 $ 115 Invoices confirmed during the year 460 Confirmed invoices paid during the year (451) Confirmed obligations outstanding at September 30, 2024 $ 124 Obligations for Customers and Other Third Parties The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At September 30, 2024, December 31, 2023 and September 30, 2023, the company had directly guaranteed $75 million, $84 million and $73 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. Of the maximum future payments at September 30, 2024, approximately $15 million had terms greater than one year. The maximum future payments include $4 million, $2 million and $4 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively, of guarantees related to the various factoring agreements into which the company enters with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable - Net, to the interim Consolidated Financial Statements, for additional information. The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $598 million, $187 million and $492 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used. Indemnifications under Separation Agreements The company has entered into various agreements where the company is indemnified for certain liabilities. The term of this indemnification is generally indefinite, with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. Chemours Separation Agreement (Performance Chemicals) Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EIDP settled multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the Performance Chemicals segment of EIDP and is now owned and/or operated by Chemours. On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EIDP, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims proceeded (the “Arbitration”). On January 22, 2021, Chemours, DuPont, Corteva and EIDP entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaced the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of the escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow account contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%. Under the terms of the MOU, Corteva’s estimated aggregate share of the potential $2 billion is approximately $600 million. In order to support and manage any potential future PFAS liabilities, the parties also agreed to establish an escrow account (“MOU Escrow Account”). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million, pursuant to the terms of the Letter Agreement. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029, pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend. The company made its annual installment deposits due to the MOU Escrow Account through September 30, 2024. In April 2024, Corteva, EIDP, DuPont, and Chemours received a final judgment resolving all drinking water claims related to PFAS of a defined class of U.S. public water systems that serve the vast majority of the United States population (the “Nationwide Water District Settlement”). In connection with the Nationwide Water District Settlement, the MOU was supplemented to waive funding due to the MOU Escrow Account by Chemours, DuPont and Corteva for 2023 provided that each party fully funds its portion of the Nationwide Water District Settlement and said settlement is consummated. The funding obligation to the MOU Escrow Account with respect to 2024 and due September 30, 2024 was to be waived if (i) between October 1, 2023 and September 30, 2024, the parties had entered into settlement agreements resolving liabilities under the MOU that in the aggregate exceed $100 million; (ii) each company had fully funded its respective share, in accordance with the MOU, of such settlements; and (iii) such settlements were consummated. No such waiver was triggered for the 2024 escrow funding obligation due September 30, 2024 and, therefore, the company made its required contribution. After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties dismissed the pending arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU. Corteva Separation Agreement On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement ("TMA"), the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow assets, employees, certain liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) and provides for indemnification obligation among the parties. Under the Corteva Separation Agreement, DuPont indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution, Dow indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that relate to the Historical Dow business, and Corteva indemnifies DuPont and Dow for certain liabilities. Indemnification matters under the Corteva Separation Agreements contain dispute resolution clauses. Corteva and DuPont are pursuing a resolution of a matter under the terms of the TMA. The company believes its interpretation of the TMA is correct, but it is reasonably possible that the required third party assessment may differ from our interpretation, which could have a significant impact to the current carrying value of our indemnification liability. Under the terms of the TMA, the dispute resolution process is expected to be concluded in the first half of 2025. Under the Corteva Separation Agreements, certain legacy EIDP liabilities from discontinued and/or divested operations and businesses of EIDP (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva and DuPont (which may include a specified amount of liability associated with that liability), Corteva and DuPont are responsible for liabilities in an amount up to that specified amount plus an additional $200 million each. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont managed such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold was met, the companies share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. The aggregate amount of cash remitted by Corteva has exceeded the stray liability thresholds, including PFAS, noted above. At September 30, 2024, December 31, 2023 and September 30, 2023, the indemnification assets were $36 million, $44 million and $36 million, respectively, within accounts and notes receivable - net and $129 million, $104 million and $126 million, respectively, within other assets in the interim Consolidated Balance Sheets. At September 30, 2024, December 31, 2023 and September 30, 2023, the indemnification liabilities were $19 million, $30 million and $38 million, respectively, within accrued and other current liabilities and $141 million, $106 million and $108 million, respectively, within other noncurrent obligations in the interim Consolidated Balance Sheets. Discontinued Operations Activity The company recorded benefits (charges) of $(2) million and $45 million for the three and nine months ended September 30, 2024, respectively, and $(3) million and $(174) million, respectively, for the three and nine months ended September 30, 2023 to income (loss) from discontinued operations after income taxes, in the interim Consolidated Statements of Operations. The after-tax charge for the three months ended September 30, 2024 was primarily driven by litigation-related activity. The after-tax benefits recognized during the nine months ended September 30, 2024 was driven by charges recognized relating to the MOU with Chemours and DuPont relating to PFAS environmental remediation activities primarily at Chemours' Fayetteville Works facility and litigation-related activity, more than offset by a favorable adjustment of certain prior year tax positions for previously divested businesses and the derecognition of an indemnification liability associated with the Water District Settlement Fund contribution. The after-tax charges recognized during the three and nine months ended September 30, 2023 primarily related to the settlement of certain legacy PFAS related legal matters that are subject to the MOU, including the Nationwide Water District Settlement. Litigation The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EIDP businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, for which the ultimate liability could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company. Lorsban ® Lawsuits As of September 30, 2024, there were pending personal injury lawsuits filed and additional asserted claims against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the Merger and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. As of September 30, 2024, an accrual has been established for the estimated resolution of certain claims. Federal Trade Commission Investigation On May 26, 2020, Corteva received a subpoena from the Federal Trade Commission (“FTC”) directing it to submit documents pertaining to its Crop Protection products generally, as well as business plans, rebate programs, offers, pricing and marketing materials specifically related to its acetochlor, oxamyl, rimsulfuron and other related products in order to determine whether Corteva engaged in unfair methods of competition through anticompetitive conduct. Corteva has fully cooperated with all requests related to this subpoena. On September 29, 2022, the FTC, along with ten state attorneys general in California, Colorado, Illinois, Indiana, Iowa, Minnesota, Nebraska, Oregon, Wisconsin, and Texas, filed a lawsuit against Corteva and another competitor alleging the parties engaged in unfair methods of competition, unlawful conditioning of payments, unreasonably restrained trade, and have an unlawful monopoly (the “FTC lawsuit”). In December 2022, attorneys general in Tennessee and Washington joined the FTC lawsuit and the Arkansas state attorney general filed a separate lawsuit against Corteva and another competitor based on the allegations set forth in the FTC lawsuit. Several proposed private class action lawsuits were also filed in federal court alleging anticompetitive conduct based on the allegations set forth in the FTC lawsuit. Virtually all of these private lawsuits were centralized into a multi-district litigation in the U.S. District Court for the Middle District of North Carolina. Corteva expects to continue a meritorious defense of its business practices. Bayer Dispute In August 2022, Bayer filed a breach of contract/declaratory judgment lawsuit in Delaware state court against Corteva relating to an agrobacterium cross-license agreement and E3® soybeans. Bayer alleges that Corteva practiced two Bayer patents in developing E3® soybeans, and therefore, is entitled to royalties pursuant to the terms of the cross-license agreement. In April 2023, Corteva's motion to dismiss the complaint on the basis that, under the terms of the cross-license agreement and the law, E3® soybeans cannot infringe expired patents was denied. At that time the court also denied Bayer’s motion to dismiss our invalidity counterclaim. Recently Corteva asserted a counterclaim against Bayer for inequitable conduct during the patent prosecution process, which Bayer has moved to dismiss. A ruling on the patent claims construction is expected by the end of 2024 and the trial date is currently scheduled for June 2025. Litigation related to legacy EIDP businesses unrelated to Corteva’s current businesses For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs"). EIDP is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective. Leach Settlement and Ohio MDL Settlement EIDP has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EIDP, which alleged that PFOA from EIDP’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EIDP to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of September 30, 2024, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million. The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for approximately $670 million in cash, with Chemours and EIDP (without indemnification from Chemours) each paying half. Post-MDL Settlement PFOA Personal Injury Claims The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. In January 2021, Chemours, DuPont and Corteva agreed to settle approximately 95 filed and unfiled matters remaining in the Ohio MDL for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company paid $27 million during the year ended December 31, 2021. The defendants have reached a tentative settlement of all of the currently filed and unfiled personal injury cases in the Ohio MDL contingent upon the court dissolving the MDL. As of September 30, 2024, an accrual has been established for the estimated resolution of these claims. Other PFOA Matters EIDP is a party to other PFOA lawsuits involving claims for property damage, medical monitoring and personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EIDP would prevail on the merits of these claims. EIDP did not make any film-forming foams, PFOS, or PFOS products. While EIDP made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EIDP’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EIDP has never made or sold PFOA as a commercial product. In April 2024, the U.S. Environmental Protection Agency ("EPA") announced that it established a maximum contaminant level in drinking water for certain PFOA, including four parts per trillion for PFOA and PFOS, individually, and ten parts per trillion for Dimer Acid (“GenX”). In April 2024, the EPA also designated PFOA and PFAS as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). Aqueous Film-Forming Foams. Approximately 4,500 cases remain filed against 3M and other defendants, including EIDP and Chemours, and some including Corteva and DuPont, alleging personal injury (primarily prostate, kidney, and testicular cancer) from the use of aqueous film-forming foams (“AFFF”) and consolidated in a multi-district litigation proceeding in federal district court in South Carolina (“SC MDL”). Most of these recent cases also assert claims that the EIDP and Chemours separation constituted a fraudulent conveyance. The SC MDL ordered the dismissal of plaintiff claims by September 10, 2024, without prejudice, if such plaintiff could not produce peer reviewed science and expert reports supporting PFAS as both the general and specific causation of their personal injury. The trial for the first potential bellwether personal injury cases are expected to begin in October 2025. Additionally, in December 2023, a class action was filed in Canada against 3M and other defendants, including EIDP and Chemours, alleging PFOS and PFOA environmental contamination and personal injury from use of AFFF. Nationwide Water District Settlement. In April 2024, Corteva, EIDP, DuPont, and Chemours (collectively, the “settling companies”) comprehensively resolved all drinking water claims related to PFAS of a defined class of U.S. public water systems that serve the vast majority of the United States population, including, but not limited to the AFFF claims in the SC MDL, under the Nationwide Water District Settlement. PFAS, as defined in the settlement, includes PFOA and HFPO-DA, among a broad range of fluorinated organic substances. The Nationwide Water District Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by Corteva or EIDP. The class represented by the Nationwide Water District Settlement is composed of all Public Water Systems, as defined in 42 U.S.C. § 300f, with a current detection of PFAS or that are currently required to monitor for PFAS under the Environmental Protection Agency’s Fifth Unregulated Contaminant Monitoring Rule (“UCMR 5”) or other applicable federal or state law (the “Class”). Approximately 88 percent of the U.S. is served by systems required to test under UCMR 5. The Class does not include water systems owned and operated by a State or the United States government; small systems that have not detected the presence of PFAS and are not currently required to monitor for it under federal or state requirements; and, unless they otherwise request to be included, water systems in the lower Cape Fear River Basin of North Carolina. The total number of requests for exclusion (“opt-outs”) was approximately 900 water districts, while most public water districts (approximately 93 percent of the Class) remain in the class settlement. New Jersey . In late March 2019, the New Jersey State Attorney General filed four lawsuits against EIDP, Chemours, and others alleging that operations at and discharges from former EIDP sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. DuPont and Corteva were subsequently added as defendants to these lawsuits. These lawsuits include claims under the New Jersey Industrial Site Recovery Act (“ISRA”) and for fraudulent conveyance. These cases are proceeding to trial with the Chambers Works site case expected to begin in June 2025. EIDP and Chemours are also defendants in two lawsuits by a private water utility provider in New Jersey and New York alleging damages from PFAS releases into the environment, that impacted water sources that the utilities use to provide water, as well as product liability, negligence, nuisance, and trespass claims. The court dismissed the New York plaintiff's trespass claims and limited plaintiffs’ nuisance claims to abatement damages. Ohio . EIDP is a defendant in two lawsuits, including an action by the State of Ohio based on alleged damage to natural resources. The natural resources damage claim was settled in December 2023 for $110 million and received final approval under Ohio's judicial consent order process. Pending any permitted appeals, Corteva’s share of the settlement under the MOU will be approximately $16 million. The second, a putative nationwide class action ("the Hardwick Class Action") brought on behalf of anyone who has detectable levels of PFAS in their blood serum seeks declaratory and injunctive relief, including the establishment of a “PFAS Science Panel”. In December 2023, the Sixth Circuit Court of Appeals dismissed the Hardwick Class Action due to lack of standing by Mr. Hardwick. With further opportunities for appeals expired, the plaintiffs filed a new case, narrowing their original claims, in June 2024. New York . EIDP is a defendant in a putative class action (the "Baker Class Action"), brought by persons who live in and around Hoosick Falls, New York asserting claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls. The lawsuits allege that EIDP and others supplied materials used at these facilities resulting in PFOA air and water contamination. A court approved settlement was reached between the plaintiffs and the other co-defendants regarding the Baker Class Action case. In September 2022, the class certification of the Baker Class Action was granted, with the court certifying three separate classes consisting of a private well property damage class, a medical monitoring class and a nuisance class. EIDP will challenge the certification and continue to defend itself on the merits of the case, while seeking an out of court resolution. EIDP is a defendant in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s water wells. This district submitted

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	STOCKHOLDERS' EQUITY Share Buyback Plan On September 13, 2022, Corteva, Inc. announced that its Board of Directors authorized a $2 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2022 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2022 Share Buyback Plan, the company repurchased and retired 4,722,000 shares and 4,913,000 shares in the open market for a total cost (excluding excise taxes) of $250 million for both the three months ended September 30, 2024 and 2023, respectively, and 13,838,000 shares and 6,330,000 shares in the open market for a total cost (excluding excise taxes) of $750 million and $330 million during the nine months ended September 30, 2024 and 2023 respectively. On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The company completed the 2021 Share Buyback Plan during the first quarter of 2023 and repurchased and retired 4,098,000, 17,425,000 and 5,572,000 shares in the open market for a total cost of $250 million, $1 billion and $250 million during the years ended December 31, 2023, 2022 and 2021, respectively. Shares repurchased pursuant to Corteva's share buyback plans are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to additional paid-in capital ("APIC"). When Corteva has retained earnings, the excess is charged entirely to retained earnings. Noncontrolling Interest Corteva, Inc. owns 100 percent of the outstanding common shares of EIDP. However, EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Consolidated Balance Sheets. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution. Below is a summary of the EIDP Preferred Stock at September 30, 2024, December 31, 2023 and September 30, 2023, which is classified as noncontrolling interests in Corteva's interim Consolidated Balance Sheets. (Shares in thousands) Number of Shares Authorized 23,000 $4.50 Series, callable at $120 1,673 $3.50 Series, callable at $102 700 Other Comprehensive Income (Loss) The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below: (In millions) Cumulative Translation Adjustment 1 Derivative Instruments Pension Benefit Plans Other Benefit Plans Unrealized Gain (Loss) on Investments Total 2023 Balance at January 1, 2023 $ (2,883) $ 80 $ (163) $ 160 $ — $ (2,806) Other comprehensive income (loss) before reclassifications (41) (114) 6 — — (149) Amounts reclassified from accumulated other comprehensive income (loss) — (40) — (6) — (46) Net other comprehensive income (loss) (41) (154) 6 (6) — (195) Balance at September 30, 2023 $ (2,924) $ (74) $ (157) $ 154 $ — $ (3,001) 2024 Balance at January 1, 2024 $ (2,458) $ (55) $ (353) $ 189 $ — $ (2,677) Other comprehensive income (loss) before reclassifications (206) (8) 2 — (14) (226) Amounts reclassified from accumulated other comprehensive income (loss) — 25 (1) (7) — 17 Net other comprehensive income (loss) (206) 17 1 (7) (14) (209) Balance at September 30, 2024 $ (2,664) $ (38) $ (352) $ 182 $ (14) $ (2,886) 1. The cumulative translation adjustment loss for the nine months ended September 30, 2024 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and Mexican Peso ("MXN"). The cumulative translation adjustment loss for the nine months ended September 30, 2023 was primarily driven by the strengthening of the USD against the South African Rand ("ZAR") and Euro ("EUR"), partially offset by the weakening of the USD against the Brazilian Real (BRL). The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows: Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Derivative instruments $ (4) $ (3) $ (13) $ 59 Pension benefit plans - net — — — — Other benefit plans - net 1 1 3 2 Unrealized gains (losses) on investments — — — — (Provision for) benefit from income taxes related to other comprehensive income (loss) items $ (3) $ (2) $ (10) $ 61 A summary of the reclassifications out of accumulated other comprehensive income (loss) is provided as follows: Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Derivative instruments 1 : $ 12 $ 16 $ 38 $ (50) Tax (benefit) expense 2 (4) (5) (13) 10 After-tax $ 8 $ 11 $ 25 $ (40) Amortization of pension benefit plans: Prior service (benefit) cost 3,4 $ (1) $ — $ (2) $ (2) Settlement (gain) loss 3,4 1 1 1 1 Total before tax $ — $ 1 $ (1) $ (1) Tax (benefit) expense 2 (1) — — 1 After-tax $ (1) $ 1 $ (1) $ — Amortization of other benefit plans: Prior service (benefit) cost 3,4 $ — $ (1) $ (1) $ (1) Actuarial (gains) loss 3,4 (3) (2) (9) (7) Total before tax $ (3) $ (3) $ (10) $ (8) Tax (benefit) expense 2 1 1 3 2 After-tax $ (2) $ (2) $ (7) $ (6) Total reclassifications for the period, after-tax $ 5 $ 10 $ 17 $ (46) 1. Reflected in cost of goods sold in the interim Consolidated Statements of Operations. 2. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. 3. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, to the interim Consolidated Financial Statements, for additional information. 4.

Pension Plans and Other Post Em

Pension Plans and Other Post Employment Benefit Plans	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Pension and other Post Employment Benefits	PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits ("OPEB"): Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Defined Benefit Pension Plans: Service cost $ 3 $ 3 $ 12 $ 13 Interest cost 162 171 488 518 Expected return on plan assets (133) (151) (399) (454) Amortization of prior service (benefit) cost — — (2) (2) Settlement loss 1 1 1 1 Net periodic benefit (credit) cost $ 33 $ 24 $ 100 $ 76 Other Post Employment Benefits: Service cost $ — $ 1 $ — $ 1 Interest cost 11 12 31 36 Amortization of unrecognized (gain) loss (3) (2) (9) (7) Amortization of prior service (benefit) cost (1) (1) (1) (1) Net periodic benefit (credit) cost $ 7 $ 10 $ 21 $ 29

Financial Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments Disclosure [Text Block]	FINANCIAL INSTRUMENTS At September 30, 2024, December 31, 2023 and September 30, 2023, the company had $1,543 million, $1,746 million and $1,619 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents in the interim Consolidated Balance Sheets, as these securities had maturities of three months or less at the time of purchase; $56 million, $98 million and $108 million of held-to-maturity securities (primarily time deposits and foreign government bonds) classified as marketable securities in the interim Consolidated Balance Sheets at September 30, 2024, December 31, 2023 and September 30, 2023, respectively, as these securities had maturities of more than three months to less than one year at the time of purchase; and $55 million of held-to-maturity securities (primarily foreign government bonds) classified as marketable securities and included in other assets in the interim Consolidated Balance Sheets at December 31, 2023, as these securities had maturities of more than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at September 30, 2024, the company had $16 million and $90 million of available-for-sale securities (primarily foreign government bonds) classified as marketable securities and other assets, respectively, in the interim Consolidated Balance Sheets, as these securities had maturities of more than three months to less than one year and more than one year, respectively, at the time of purchase. The company’s held-to-maturity and available-for-sale securities relating to investments in foreign government bonds at September 30, 2024 are discussed further in the “Debt Securities” section. Derivative Instruments Objectives and Strategies for Holding Derivative Instruments In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk. Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments. The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management. The aggregate notional amounts for the company's derivative instruments (both designated and not designated) was a net buy (sell) position of $1,305 million, $(1,600) million and $2,199 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. Foreign Currency Risk The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows. The company uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries. Commodity Price Risk Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures. Derivatives Designated as Cash Flow Hedges Commodity Contracts The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, forwards, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures. While each risk management program has a different maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring. The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive income (loss): Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Beginning balance $ (92) $ (71) $ (71) $ 55 Additions and revaluations of derivatives designated as cash flow hedges 25 (20) (13) (94) Clearance of hedge results to earnings 7 2 24 (50) Ending balance $ (60) $ (89) $ (60) $ (89) At September 30, 2024, an after-tax net loss of $70 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months. Foreign Currency Contracts The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries. While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring. The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive income (loss): Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Beginning balance $ 20 $ (16) $ 1 $ 10 Additions and revaluations of derivatives designated as cash flow hedges — 7 19 (20) Clearance of hedge results to earnings 1 9 1 10 Ending balance $ 21 $ — $ 21 $ — At September 30, 2024, an after-tax net gain of $21 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months. Derivatives Designated as Net Investment Hedges Foreign Currency Contracts In May 2024, the company designated €500 million of forward contracts to exchange Euro as net investment hedges. An additional tranche of €500 million of forward contracts to exchange Euro were executed in July 2024 and also designated as net investment hedges. The purpose of these forward contracts is to mitigate foreign exchange exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in December 2024. The company had previously designated €1.2 billion and €450 million of forward contracts to exchange Euro as net investment hedges, which expired and were settled in May 2024 and March 2023, respectively. The company elected to apply the spot method in testing for effectiveness of the hedging relationship. Derivatives not Designated in Hedging Relationships Foreign Currency Contracts The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period. Commodity Contracts The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses commodity contracts to offset a portion of the company’s exposure to commodity price fluctuations so that gains and losses on the contracts offset changes in the commodity price over the relevant aggregate period. The company uses forward agreements, with durations less than one year, to buy and sell USD-priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures. Fair Value of Derivative Instruments Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows: September 30, 2024 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Commodity contracts Other current assets $ 2 $ — $ 2 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 105 (61) 44 Commodity contracts Other current assets 3 — 3 Total asset derivatives $ 110 $ (61) $ 49 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 23 $ — $ 23 Commodity contracts Accrued and other current liabilities 1 — 1 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 64 (61) 3 Commodity contracts Accrued and other current liabilities 3 — 3 Total liability derivatives $ 91 $ (61) $ 30 December 31, 2023 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Commodity contracts Other current assets $ 3 $ — $ 3 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 83 (33) 50 Commodity contracts Other current assets 2 — 2 Total asset derivatives $ 88 $ (33) $ 55 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 23 $ — $ 23 Commodity contracts Accrued and other current liabilities 6 — 6 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 38 (33) 5 Commodity contracts Accrued and other current liabilities 8 — 8 Total liability derivatives $ 75 $ (33) $ 42 September 30, 2023 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 7 $ — $ 7 Commodity Contracts Other current assets 1 — 1 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 45 (39) 6 Total asset derivatives $ 53 $ (39) $ 14 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 7 $ — $ 7 Commodity contracts Accrued and other current liabilities 3 — 3 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 87 (39) 48 Commodity contracts Accrued and other current liabilities 3 — 3 Total liability derivatives $ 100 $ (39) $ 61 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Effect of Derivative Instruments Amount of Gain (Loss) Recognized in OCI - Pre-Tax 1 Three Months Ended Nine Months Ended (In millions) 2024 2023 2024 2023 Derivatives designated as hedging instruments: Net investment hedges: Foreign currency contracts $ (36) $ — $ (19) $ — Cash flow hedges: Foreign currency contracts 1 11 29 (30) Commodity contracts 34 (26) (18) (133) Total derivatives designated as hedging instruments $ (1) $ (15) $ (8) $ (163) 1. OCI is defined as other comprehensive income (loss). Amount of Gain (Loss) Recognized in Income - Pre-Tax 1 Three Months Ended Nine Months Ended (In millions) 2024 2023 2024 2023 Derivatives designated as hedging instruments: Cash flow hedges: Foreign currency contracts 2 $ (2) $ (13) $ (3) $ (15) Commodity contracts 2 (10) (3) (35) 65 Total derivatives designated as hedging instruments $ (12) $ (16) $ (38) $ 50 Derivatives not designated as hedging instruments: Foreign currency contracts 3 $ 59 $ (3) $ (32) $ (65) Foreign currency contracts 2 (6) 4 12 (67) Commodity contracts 2,4 3 1 (41) 4 Commodity contracts 3 1 5 (2) 5 Total derivatives not designated as hedging instruments $ 57 $ 7 $ (63) $ (123) Total derivatives $ 45 $ (9) $ (101) $ (73) 1. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. 2. Recorded in cost of goods sold in the interim Consolidated Statements of Operations. 3. Recognized in other income (expense). Note that net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information. 4. The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the interim Consolidated Statements of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities. Debt Securities The company’s debt securities include foreign government bonds classified as held-to-maturity securities at September 30, 2024, December 31, 2023 and September 30, 2023, and available-for-sale securities at September 30, 2024. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value, and are held by certain foreign subsidiaries in which the USD is the functional currency. The debt securities classified as held-to-maturity at September 30, 2024 with a contractual maturity within one year was $55 million. The company’s investments in debt securities classified as available-for-sale are recorded at fair value with unrealized gains and losses recorded in accumulated other comprehensive income (loss), within the interim Consolidated Statements of Equity, or current period earnings if an allowance for credit losses has been established, within the interim Consolidated Statements of Operations. The debt securities classified as available-for-sale at September 30, 2024 with a contractual maturity within one year had an amortized cost of $17 million, gross unrealized gains (losses) of $(1) million and a fair value of $16 million. The debt securities classified as available-for-sale at September 30, 2024 with a contractual maturity of one to five years had an amortized cost of $103 million, gross unrealized gains (losses) of $(13) million and a fair value of $90 million.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis: September 30, 2024 December 31, 2023 September 30, 2023 (In millions) Level 2 1 Level 2 1 Level 2 1 Assets at fair value: Marketable securities $ 56 $ 98 $ 108 Debt securities: Foreign government bonds 2 106 — — Derivatives relating to: 3 Foreign currency 105 83 52 Commodity contracts 5 5 1 Total assets at fair value $ 272 $ 186 $ 161 Liabilities at fair value: Derivatives relating to: 3 Foreign currency $ 87 $ 61 $ 94 Commodity contracts 4 14 6 Total liabilities at fair value $ 91 $ 75 $ 100 1. Reflects significant other observable inputs. 2. Represents the company's investments in debt securities that are classified as available-for-sale, which are included in marketable securities and other assets in the interim Consolidated Balance Sheets. 3. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Segment Reporting (Notes)

Segment Reporting (Notes)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (Seed and Crop Protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EIDP businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. As of and for the Three Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 691 $ 1,635 $ 2,326 Segment operating EBITDA (320) 246 (74) Segment assets 1 22,192 14,895 37,087 2023 Net sales $ 878 $ 1,712 $ 2,590 Segment operating EBITDA (138) 184 46 Segment assets 1 22,829 15,446 38,275 1. Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively. As of and for the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 7,773 $ 5,157 $ 12,930 Segment operating EBITDA 2,126 811 2,937 2023 Net sales $ 7,837 $ 5,682 $ 13,519 Segment operating EBITDA 1,972 1,107 3,079 Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (519) $ (315) $ 913 $ 1,172 Provision for (benefit from) income taxes on continuing operations (114) (129) 274 244 Income (loss) from continuing operations before income taxes $ (633) $ (444) $ 1,187 $ 1,416 Depreciation and amortization 306 306 925 899 Interest income (33) (59) (93) (153) Interest expense 66 58 173 171 Exchange (gains) losses 97 102 234 242 Non-operating (benefits) costs 50 28 132 115 Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 14 (44) (4) 34 Significant items (benefit) charge 33 71 297 271 Corporate expenses 26 28 86 84 Segment operating EBITDA $ (74) $ 46 $ 2,937 $ 3,079 Segment assets to total assets (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Total segment assets $ 37,087 $ 37,736 $ 38,275 Corporate assets 4,821 5,260 4,835 Total assets $ 41,908 $ 42,996 $ 43,110 Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA The three and nine months ended September 30, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA: (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2024 Restructuring and asset related charges - net 1 $ (3) $ (10) $ (19) $ (32) Acquisition-related costs 4 — (1) — (1) Total $ (3) $ (11) $ (19) $ (33) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2023 Restructuring and asset related charges - net 1 $ 1 $ — $ (3) $ (2) Estimated settlement expense 2 — (66) — (66) Gain (loss) on sale of business, assets and equity investments 3 4 — — 4 Acquisition-related costs 4 — (7) — (7) Total $ 5 $ (73) $ (3) $ (71) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2024 Restructuring and asset related charges - net 1 $ (56) $ (83) $ (60) $ (199) Estimated settlement expense 2 — (101) — (101) Inventory write-offs 3 2 — — 2 Gain (loss) on sale of assets 3 4 3 — 7 Acquisition-related costs 4 — (6) — (6) Total $ (50) $ (187) $ (60) $ (297) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2023 Restructuring and asset related charges - net 1 $ (74) $ (11) $ (10) $ (95) Estimated settlement expense 2 — (156) — (156) Inventory write-offs 3 (7) — — (7) Gain (loss) on sale of business, assets and equity investments 3 4 3 — 7 Seed sale associated with Russia Exit 3,5 18 — — 18 Acquisition-related costs 4 — (41) — (41) Employee Retention Credit — 3 — 3 Total $ (59) $ (202) $ (10) $ (271) 1. Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. 2. Consists of estimated Lorsban® related charges. 3. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. The nine months ended September 30, 2024 includes a $2 million benefit associated with sales of inventory previously reserved for in association with the 2022 Restructuring Actions. 4. Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information. 5.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSIn April 2024, the company entered into a committed receivable repurchase facility of up to XX (the "2024 Repurchase Facility"), which expires in December 20XX. Under the 2024 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2024 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to XX of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2024 Repurchase Facility have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR"), which is Term SOFR plus XX, plus the margin.

EID - Basis of Presentation (No

EID - Basis of Presentation (Notes)	9 Months Ended
	Sep. 30, 2024
EIDP
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	BASIS OF PRESENTATION Corteva, Inc. owns 100% of the outstanding common stock of EIDP. EIDP is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EIDP are outlined below: • Preferred Stock - EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution. • Related Party Loan - EIDP engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remained on EIDP's consolidated financial statements at the standalone level (including the associated interest) through its repayment date in the fourth quarter of 2023. • Capital Structure - At September 30, 2024, Corteva, Inc.'s capital structure consists of 689,170,000 issued shares of common stock, par value $0.01 per share. The accompanying footnotes relate to EIDP only, and not to Corteva, Inc., and are presented to show differences between EIDP and Corteva, Inc. For the footnotes listed below, refer to the following Corteva, Inc. footnotes: • Note 1 - Summary of Significant Accounting Policies - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements • Note 2 - Recent Accounting Guidance - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements • Note 3 - Business Combinations - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements • Note 4 - Revenue - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements • Note 5 - Restructuring and Asset Related Charges - Net - refer to page 12 of the Corteva, Inc. interim Consolidated Financial Statements • Note 6 - Supplementary Information - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EIDP has a related party loan receivable from Corteva, Inc.; refer to EIDP Note 2 - Related Party Transactions, below. • Note 7 - Income Taxes - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 3 - Income Taxes, of the EIDP interim Consolidated Financial Statements, below • Note 8 - Earnings Per Share of Common Stock - Not applicable for EIDP • Note 9 - Accounts and Notes Receivable - Net - refer to page 18 of the Corteva, Inc. interim Consolidated Financial Statements • Note 10 - Inventories - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements • Note 11 - Other Intangible Assets - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements • Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EIDP had a related party loan payable to Corteva, Inc. which was repaid during the fourth quarter of 2023; refer to EIDP Note 2 - Related Party Transactions, below. • Note 13 - Commitments and Contingent Liabilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements • Note 14 - Stockholders' Equity - refer to page 30 of the Corteva, Inc. interim Consolidated Financial Statements • Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 32 of the Corteva, Inc. interim Consolidated Financial Statements • Note 16 - Financial Instruments - refer to page 33 of the Corteva, Inc. interim Consolidated Financial Statements • Note 17 - Fair Value Measurements - refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements • Note 18 - Segment Information - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 4 - Segment Information, below

EIDP - Related Party Transactio

EIDP - Related Party Transactions (Notes)	9 Months Ended
	Sep. 30, 2024
EIDP
Related Party Transaction [Line Items]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with Corteva In the second quarter of 2019, EIDP entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. EIDP repaid the outstanding related party revolving loan balance during the fourth quarter of 2023. As of September 30, 2023, the outstanding related party loan balance was $115 million (which approximates fair value), with an interest rate of 7.00%. The balance at September 30, 2023 was reflected as short-term borrowings - related party in EIDP's interim Consolidated Balance Sheets. Additionally, EIDP incurred interest expense of $2 million and $22 million for the three and nine months ended September 30, 2023, respectively, associated with the related party loan from Corteva, Inc., net of interest income earned from the below-noted Master In-House Banking Agreement. EIDP and Corteva, including certain consolidated subsidiaries (collectively the “Participating Companies”), are party to a Master In-House Banking Agreement, which established banking arrangements to facilitate the management of the cash and liquidity needs of the Participating Companies. EIDP had receivables from Corteva, Inc. of $1,505 million, $377 million, and $217 million related to this agreement included in other assets in EIDP's interim Consolidated Balance Sheets as of September 30, 2024, December 31, 2023, and September 30, 2023 respectively. Additionally, EIDP earned interest income from Corteva, Inc. of $18 million and $38 million under this agreement for the three and nine months ended September 30, 2024, respectively, which is reflected as other income (expense) - net in EIDP's interim Consolidated Statements of Operations. As of September 30, 2024, December 31, 2023 and September 30, 2023, EIDP had payables to Corteva, Inc., of $19 million, $30 million and $38 million included in accrued and other current liabilities, respectively, and $141 million, $106 million and $108 million, included in other noncurrent obligations, respectively, in the interim Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 23 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).

EIDP Income Taxes (Notes)

EIDP Income Taxes (Notes)	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Text Block]	INCOME TAXES The effective tax rate for the three and nine months ended September 30, 2024 was 18.0 percent and 23.1 percent, respectively, and 29.1 percent and 17.2 percent for the three and nine months ended September 30, 2023, respectively. During the three and nine months ended September 30, 2024, the company recognized $10 million and $25 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes and accruals for certain prior year tax positions in various jurisdictions as well as from stock-based compensation. During the three and nine months ended September 30, 2023, the company recognized $11 million and $79 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes, accruals for certain prior year tax positions in various jurisdictions, stock-based compensation, as well as the impact of changes to deferred taxes associated with a tax currency change for a legal entity. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information, to the interim Consolidated Financial Statements.
EIDP
Income Tax Disclosure [Text Block]	INCOME TAXES Refer to page 16 of the Corteva, Inc. Interim Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EIDP. The effective tax rate was 17.9 percent and 23.1 percent for the three and nine months ended September 30, 2024 and 28.9 percent and 17.1 percent for the three and nine months ended September 30, 2023, respectively. EIDP's effective tax rates for the three and nine months ended September 30, 2024 and 2023 were driven by the net tax benefits discussed on page 16 of the Corteva, Inc. Interim Consolidated Financial Statements.

EIDP Segment FN (Notes)

EIDP Segment FN (Notes)	9 Months Ended
	Sep. 30, 2024
Segment Reporting Information [Line Items]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (Seed and Crop Protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EIDP businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. As of and for the Three Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 691 $ 1,635 $ 2,326 Segment operating EBITDA (320) 246 (74) Segment assets 1 22,192 14,895 37,087 2023 Net sales $ 878 $ 1,712 $ 2,590 Segment operating EBITDA (138) 184 46 Segment assets 1 22,829 15,446 38,275 1. Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively. As of and for the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 7,773 $ 5,157 $ 12,930 Segment operating EBITDA 2,126 811 2,937 2023 Net sales $ 7,837 $ 5,682 $ 13,519 Segment operating EBITDA 1,972 1,107 3,079 Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (519) $ (315) $ 913 $ 1,172 Provision for (benefit from) income taxes on continuing operations (114) (129) 274 244 Income (loss) from continuing operations before income taxes $ (633) $ (444) $ 1,187 $ 1,416 Depreciation and amortization 306 306 925 899 Interest income (33) (59) (93) (153) Interest expense 66 58 173 171 Exchange (gains) losses 97 102 234 242 Non-operating (benefits) costs 50 28 132 115 Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 14 (44) (4) 34 Significant items (benefit) charge 33 71 297 271 Corporate expenses 26 28 86 84 Segment operating EBITDA $ (74) $ 46 $ 2,937 $ 3,079 Segment assets to total assets (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Total segment assets $ 37,087 $ 37,736 $ 38,275 Corporate assets 4,821 5,260 4,835 Total assets $ 41,908 $ 42,996 $ 43,110 Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA The three and nine months ended September 30, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA: (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2024 Restructuring and asset related charges - net 1 $ (3) $ (10) $ (19) $ (32) Acquisition-related costs 4 — (1) — (1) Total $ (3) $ (11) $ (19) $ (33) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2023 Restructuring and asset related charges - net 1 $ 1 $ — $ (3) $ (2) Estimated settlement expense 2 — (66) — (66) Gain (loss) on sale of business, assets and equity investments 3 4 — — 4 Acquisition-related costs 4 — (7) — (7) Total $ 5 $ (73) $ (3) $ (71) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2024 Restructuring and asset related charges - net 1 $ (56) $ (83) $ (60) $ (199) Estimated settlement expense 2 — (101) — (101) Inventory write-offs 3 2 — — 2 Gain (loss) on sale of assets 3 4 3 — 7 Acquisition-related costs 4 — (6) — (6) Total $ (50) $ (187) $ (60) $ (297) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2023 Restructuring and asset related charges - net 1 $ (74) $ (11) $ (10) $ (95) Estimated settlement expense 2 — (156) — (156) Inventory write-offs 3 (7) — — (7) Gain (loss) on sale of business, assets and equity investments 3 4 3 — 7 Seed sale associated with Russia Exit 3,5 18 — — 18 Acquisition-related costs 4 — (41) — (41) Employee Retention Credit — 3 — 3 Total $ (59) $ (202) $ (10) $ (271) 1. Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. 2. Consists of estimated Lorsban® related charges. 3. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. The nine months ended September 30, 2024 includes a $2 million benefit associated with sales of inventory previously reserved for in association with the 2022 Restructuring Actions. 4. Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information. 5.
EIDP
Segment Reporting Information [Line Items]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION There are no differences in reporting structure or segments between Corteva, Inc. and EIDP. In addition, there are no differences between Corteva, Inc. and EIDP segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EIDP. Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA Three Months Ended Nine Months Ended (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (505) $ (317) $ 942 $ 1,155 Provision for (benefit from) income taxes on continuing operations (110) (129) 283 239 Income (loss) from continuing operations before income taxes $ (615) $ (446) $ 1,225 $ 1,394 Depreciation and amortization 306 306 925 899 Interest income (51) (59) (131) (153) Interest expense 66 60 173 193 Exchange (gains) losses 97 102 234 242 Non-operating (benefits) costs 50 28 132 115 Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 14 (44) (4) 34 Significant items (benefit) charge 33 71 297 271 Corporate expenses 26 28 86 84 Segment operating EBITDA $ (74) $ 46 $ 2,937 $ 3,079

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2023, collectively referred to as the “2023 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. The interim Consolidated Financial Statements and other financial information included in this Form 10-Q, unless otherwise specified, have been presented to separately show the effects of discontinued operations. During the fourth quarter of 2023, the company made the decision, which was retrospectively applied, to adjust the presentation of the interim Consolidated Statement of Cash Flows to separately present the cash provided by (used for) operating activities – discontinued operations, which was previously presented within cash provided by (used for) operating activities. See Note 13 – Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information on discontinued operations activities. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 4 percent to the company's annual net sales and less than 4 percent to each of the company's annual Seed and Crop Protection segment operating EBITDA. The company remeasures net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 7 – Supplementary Information, to the Consolidated Financial Statements, in the company's 2023 Annual Report). The Argentina government has offered USD-denominated bonds to importers, the proceeds from which could be used to pay off outstanding intercompany payables. During the first quarter of 2024, the company purchased $125 million of these foreign government bonds as part of its strategy to manage its net monetary asset exposure in Argentina. Refer to the “Debt Securities” section in Note 16 - Financial Instruments, to the interim Consolidated Financial Statements, for additional information. As of September 30, 2024, a further 10 percent deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of our net monetary assets or pre-tax earnings. The company will continue to assess the implications to our operations and financial reporting.

Recent Accounting Guidance Rece

Recent Accounting Guidance Recent Accounting Guidance (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement. The amendments in this ASU are intended to facilitate consistency in the application of accounting guidance upon the formation of entities qualifying as joint ventures. It generally requires the use of business combinations accounting at the joint venture formation date, which would result in the contributed assets/liabilities being revalued to fair value and potentially result in the recognition of goodwill and other intangible assets on the joint venture’s financial statements. It does not alter the ongoing accounting for the joint venture’s operations. This guidance is effective for joint ventures with formation dates on or after January 1, 2025. Prospective application is required, with early adoption permitted. Retrospective application can be elected for joint ventures formed before January 1, 2025. Beginning in the third quarter of 2024, newly-formed joint ventures have applied this guidance. Accounting Guidance Issued But Not Adopted as of September 30, 2024 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance will result in the company being required to include enhanced income tax related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment’s profit or loss measure(s) that are regularly provided to the chief operating decision maker (the “CODM”) to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The company will adopt this guidance upon its effective date and will include enhanced disclosures relating to its reportable segments for all subsequent annual and interim periods.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2024
Disaggregation of Revenue [Line Items]
Contract Balances	Contract Balances September 30, 2024 December 31, 2023 September 30, 2023 (In millions) Accounts and notes receivable - trade 1 $ 5,501 $ 4,329 $ 5,320 Contract assets - current 2 $ 29 $ 27 $ 27 Contract assets - noncurrent 3 $ 73 $ 67 $ 67 Deferred revenue - current $ 429 $ 3,406 $ 552 Deferred revenue - noncurrent 4 $ 115 $ 108 $ 109 1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. 2. Included in other current assets in the interim Consolidated Balance Sheets. 3. Included in other assets in the interim Consolidated Balance Sheets. 4.
Major Product Line [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Corn $ 315 $ 487 $ 5,085 $ 5,139 Soybean 164 189 1,773 1,713 Other oilseeds 135 142 566 637 Other 77 60 349 348 Seed 691 878 7,773 7,837 Herbicides 736 815 2,568 3,043 Insecticides 437 416 1,225 1,156 Fungicides 216 226 761 837 Other 246 255 603 646 Crop Protection 1,635 1,712 5,157 5,682 Total $ 2,326 $ 2,590 $ 12,930 $ 13,519
Geography [Domain]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue	Seed Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 North America 1 $ 170 $ 173 $ 5,394 $ 5,192 EMEA 2 196 198 1,365 1,441 Latin America 218 380 696 847 Asia Pacific 107 127 318 357 Total $ 691 $ 878 $ 7,773 $ 7,837 Crop Protection Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 North America 1 $ 440 $ 399 $ 1,703 $ 1,901 EMEA 2 219 271 1,311 1,555 Latin America 771 844 1,458 1,537 Asia Pacific 205 198 685 689 Total $ 1,635 $ 1,712 $ 5,157 $ 5,682 1. Represents U.S. & Canada. 2. Europe, Middle East and Africa ("EMEA").

Restructuring and Asset Relat_2

Restructuring and Asset Related Charges (Tables)	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]		Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Severance and related benefit costs 1 $ — $ — $ — $ 4 Asset related charges — — (2) 11 Contract termination charges 3 3 1 3 4 Total restructuring and asset related charges - net 2,3 $ 3 $ 1 $ 1 $ 19 1. Reflects corporate-related charges. 2. The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment. 3. This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information.
Crop Protection Strategy Operations Program [Member]
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	(In millions) Three Months Ended September 30, 2024 Nine Months Ended September 30, 2024 Severance and related benefit costs 1 $ 19 $ 60 Asset related charges 2, 3 10 83 Total restructuring and asset related charges - net $ 29 $ 143 1. Reflects corporate-related charges. 2. Reflects charges associated with the Crop Protection segment. 3. The three and nine months ended September 30, 2024 include charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California. A reconciliation of the December 31, 2023 to the September 30, 2024 liability balances related to the Crop Protection Operations Strategy Restructuring Program is summarized below: (In millions) Severance and Related Benefit Costs Asset Related Charges 1 Total Balance at December 31, 2023 $ — $ — $ — Charges to income from continuing operations 60 83 143 Payments (3) (4) (7) Asset write-offs — (79) (79) Balance at September 30, 2024 $ 57 $ — $ 57

Supplementary Information (Tabl

Supplementary Information (Tables)	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Nonoperating Income (Expense)	Other Income (Expense) - Net Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Interest income $ 33 $ 59 $ 93 $ 153 Equity in earnings (losses) of affiliates - net — (2) 7 4 Net gain (loss) on sales of businesses and other assets — 10 17 11 Net exchange gains (losses) 1 (97) (102) (234) (242) Non-operating pension and other post employment benefit credits (costs) 2 (37) (30) (109) (91) Miscellaneous income (expenses) - net 3 (6) (84) (93) (189) Other income (expense) - net $ (107) $ (149) $ (319) $ (354) 1. Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively. 2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 3.
Foreign Currency Exchange Gain (Loss)	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Subsidiary Monetary Position Gain (Loss) Pre-tax exchange gain (loss) $ (156) $ (104) $ (199) $ (182) Local tax (expenses) benefits 5 19 23 27 Net after-tax impact from subsidiary exchange gain (loss) $ (151) $ (85) $ (176) $ (155) Hedging Program Gain (Loss) Pre-tax exchange gain (loss) $ 59 $ 2 $ (35) $ (60) Tax (expenses) benefits (12) (4) 7 12 Net after-tax impact from hedging program exchange gain (loss) $ 47 $ (2) $ (28) $ (48) Total Exchange Gain (Loss) Pre-tax exchange gain (loss) $ (97) $ (102) $ (234) $ (242) Tax (expenses) benefits (7) 15 30 39 Net after-tax exchange gain (loss) $ (104) $ (87) $ (204) $ (203) Non-Controlling Interest Adjustment — — 1 — Net after-tax exchange gain (loss) attributable to Corteva $ (104) $ (87) $ (203) $ (203)
Restrictions on Cash and Cash Equivalents	(In millions) September 30, 2024 December 31, 2023 September 30, 2023 Cash and cash equivalents $ 2,421 $ 2,644 $ 2,254 Restricted cash equivalents 335 514 522 Total cash, cash equivalents and restricted cash equivalents $ 2,756 $ 3,158 $ 2,776

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (519) $ (315) $ 913 $ 1,172 Net income (loss) attributable to continuing operations noncontrolling interests 3 3 10 10 Income (loss) from continuing operations available to Corteva common stockholders (522) (318) 903 1,162 Income (loss) from discontinued operations available to Corteva common stockholders (2) (3) 45 (174) Net income (loss) available to common stockholders $ (524) $ (321) $ 948 $ 988
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]	Earnings (Loss) Per Share Calculations - Basic Three Months Ended September 30, Nine Months Ended September 30, (Dollars per share) 2024 2023 2024 2023 Earnings (loss) per share of common stock from continuing operations $ (0.76) $ (0.45) $ 1.30 $ 1.64 Earnings (loss) per share of common stock from discontinued operations — — 0.06 (0.24) Earnings (loss) per share of common stock $ (0.76) $ (0.45) $ 1.36 $ 1.40
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]	Earnings (Loss) Per Share Calculations - Diluted Three Months Ended September 30, Nine Months Ended September 30, (Dollars per share) 2024 2023 2024 2023 Earnings (loss) per share of common stock from continuing operations $ (0.76) $ (0.45) $ 1.29 $ 1.63 Earnings (loss) per share of common stock from discontinued operations — — 0.06 (0.24) Earnings (loss) per share of common stock $ (0.76) $ (0.45) $ 1.35 $ 1.39
Schedule of Weighted Average Number of Shares	Share Count Information Three Months Ended September 30, Nine Months Ended September 30, (Shares in millions) 2024 2023 2024 2023 Weighted-average common shares - basic 691.1 708.4 695.8 710.7 Plus: dilutive effect of equity compensation plans 1 — — 2.5 2.9 Weighted-average common shares - diluted 691.1 708.4 698.3 713.6 Potential shares of common stock excluded from EPS calculations 2 2.5 2.2 3.4 2.4 1. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. 2. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable_2

Accounts and Notes Receivable (Tables)	9 Months Ended
	Sep. 30, 2024
Accounts and Notes Receivable [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	(In millions) September 30, 2024 December 31, 2023 September 30, 2023 Accounts receivable – trade 1 $ 4,260 $ 4,210 $ 4,013 Notes receivable – trade 1,2 1,241 119 1,307 Other 3 1,150 1,159 1,261 Total accounts and notes receivable - net $ 6,651 $ 5,488 $ 6,581 1. Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. 2. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2024, December 31, 2023 and September 30, 2023, there were no significant impairments related to current loan agreements. 3.
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	(In millions) 2023 Balance at December 31, 2022 $ 194 Net provision for credit losses 10 Other - net of write-offs charged against allowance (3) Balance at September 30, 2023 $ 201 2024 Balance at December 31, 2023 $ 205 Net provision for credit losses 31 Other - net of write-offs charged against allowance (48) Balance at September 30, 2024 $ 188

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	(In millions) September 30, 2024 December 31, 2023 September 30, 2023 Finished products $ 2,399 $ 3,273 $ 2,786 Semi-finished products 2,785 2,775 2,690 Raw materials and supplies 490 851 844 Total inventories $ 5,674 $ 6,899 $ 6,320

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	September 30, 2024 December 31, 2023 September 30, 2023 (In millions) Gross Accumulated Net Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization (finite-lived): Germplasm $ 6,291 $ (1,272) $ 5,019 $ 6,291 $ (1,081) $ 5,210 $ 6,291 $ (1,017) $ 5,274 Customer-related 2,413 (844) 1,569 2,427 (734) 1,693 2,403 (688) 1,715 Developed technology 1,838 (1,126) 712 1,849 (1,004) 845 1,845 (958) 887 Trademarks/trade names 2,056 (359) 1,697 2,111 (339) 1,772 2,110 (314) 1,796 Other 1 388 (306) 82 395 (294) 101 395 (288) 107 Total other intangible assets with finite lives 12,986 (3,907) 9,079 13,073 (3,452) 9,621 13,044 (3,265) 9,779 Intangible assets not subject to amortization (indefinite-lived): In-process research & development 5 — 5 5 — 5 16 — 16 Total other intangible assets with 5 — 5 5 — 5 16 — 16 Total other intangible assets $ 12,991 $ (3,907) $ 9,084 $ 13,078 $ (3,452) $ 9,626 $ 13,060 $ (3,265) $ 9,795 1. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Short-Term Borrowings, Long-T_2

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Instrument [Line Items]
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2026 600 4.50 % 600 4.50 % 600 4.50 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Maturing in 2033 600 4.80 % 600 4.80 % 600 4.80 % Other loans: Foreign currency loans, various rates and maturities 184 12.70 % 196 14.80 % 188 14.80 % Medium-term notes, varying maturities through 2041 104 4.94 % 106 5.34 % 106 5.33 % Finance lease obligations — 1 1 Less: Unamortized debt discount and issuance costs 13 16 17 Less: Long-term debt due within one year 500 196 188 Total long-term debt $ 1,975 $ 2,291 $ 2,290
Schedule of Short-term Debt [Table Text Block]	Short-term borrowings and finance lease obligations (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Commercial paper $ 2,969 $ — $ 3,417 364-Day Revolving Credit Facility — — — Other loans - various currencies 271 1 3 Long-term debt payable within one year 500 196 188 Finance lease obligations payable within one year 1 1 1 Total short-term borrowings and finance lease obligations $ 3,741 $ 198 $ 3,609
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2026 600 4.50 % 600 4.50 % 600 4.50 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Maturing in 2033 600 4.80 % 600 4.80 % 600 4.80 % Other loans: Foreign currency loans, various rates and maturities 184 12.70 % 196 14.80 % 188 14.80 % Medium-term notes, varying maturities through 2041 104 4.94 % 106 5.34 % 106 5.33 % Finance lease obligations — 1 1 Less: Unamortized debt discount and issuance costs 13 16 17 Less: Long-term debt due within one year 500 196 188 Total long-term debt $ 1,975 $ 2,291 $ 2,290
Schedule of Line of Credit Facilities	Committed and Available Credit Facilities at September 30, 2024 (In millions) Effective Date Committed Credit Credit Available Maturity Date Interest Revolving Credit Facility June 2024 $ 2,850 $ 2,850 June 2029 Floating Rate Revolving Credit Facility June 2024 1,900 1,900 June 2027 Floating Rate 364-Day Revolving Credit Facility February 2024 1,000 1,000 February 2025 Floating Rate Total Committed and Available Credit Facilities $ 5,750 $ 5,750

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Environmental Loss Contingencies by Site [Table Text Block]	As of September 30, 2024 (In millions) Indemnification Asset Accrual balance 3 Potential exposure above amount accrued 3 Environmental Remediation Stray Liabilities Chemours related obligations - subject to indemnity 1,2 $ 150 $ 153 $ 277 Other discontinued or divested businesses obligations 1 34 71 203 Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont 2 49 52 61 Environmental remediation liabilities not subject to indemnity — 105 90 Indemnification liabilities related to the MOU 4 26 96 13 Total $ 259 $ 477 $ 644 1. Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 23, under the header "Corteva Separation Agreement." 2. The company has recorded an indemnification asset related to these accruals, including $19 million related to the Superfund sites. 3. Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $47 million for remediation of Superfund sites. Amounts do not include all possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 28 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ"). 4. Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 22, under the header "Chemours Separation Agreement (Performance Chemicals)."

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]	(Shares in thousands) Number of Shares Authorized 23,000 $4.50 Series, callable at $120 1,673 $3.50 Series, callable at $102 700
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	(In millions) Cumulative Translation Adjustment 1 Derivative Instruments Pension Benefit Plans Other Benefit Plans Unrealized Gain (Loss) on Investments Total 2023 Balance at January 1, 2023 $ (2,883) $ 80 $ (163) $ 160 $ — $ (2,806) Other comprehensive income (loss) before reclassifications (41) (114) 6 — — (149) Amounts reclassified from accumulated other comprehensive income (loss) — (40) — (6) — (46) Net other comprehensive income (loss) (41) (154) 6 (6) — (195) Balance at September 30, 2023 $ (2,924) $ (74) $ (157) $ 154 $ — $ (3,001) 2024 Balance at January 1, 2024 $ (2,458) $ (55) $ (353) $ 189 $ — $ (2,677) Other comprehensive income (loss) before reclassifications (206) (8) 2 — (14) (226) Amounts reclassified from accumulated other comprehensive income (loss) — 25 (1) (7) — 17 Net other comprehensive income (loss) (206) 17 1 (7) (14) (209) Balance at September 30, 2024 $ (2,664) $ (38) $ (352) $ 182 $ (14) $ (2,886) 1.
Tax (Expense) Benefit of Other Comprehensive (Loss) Income	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Derivative instruments $ (4) $ (3) $ (13) $ 59 Pension benefit plans - net — — — — Other benefit plans - net 1 1 3 2 Unrealized gains (losses) on investments — — — — (Provision for) benefit from income taxes related to other comprehensive income (loss) items $ (3) $ (2) $ (10) $ 61
Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Derivative instruments 1 : $ 12 $ 16 $ 38 $ (50) Tax (benefit) expense 2 (4) (5) (13) 10 After-tax $ 8 $ 11 $ 25 $ (40) Amortization of pension benefit plans: Prior service (benefit) cost 3,4 $ (1) $ — $ (2) $ (2) Settlement (gain) loss 3,4 1 1 1 1 Total before tax $ — $ 1 $ (1) $ (1) Tax (benefit) expense 2 (1) — — 1 After-tax $ (1) $ 1 $ (1) $ — Amortization of other benefit plans: Prior service (benefit) cost 3,4 $ — $ (1) $ (1) $ (1) Actuarial (gains) loss 3,4 (3) (2) (9) (7) Total before tax $ (3) $ (3) $ (10) $ (8) Tax (benefit) expense 2 1 1 3 2 After-tax $ (2) $ (2) $ (7) $ (6) Total reclassifications for the period, after-tax $ 5 $ 10 $ 17 $ (46) 1. Reflected in cost of goods sold in the interim Consolidated Statements of Operations. 2. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. 3. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, to the interim Consolidated Financial Statements, for additional information. 4.

Pension Plans and Other Post _2

Pension Plans and Other Post Employment Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Defined Benefit Pension Plans: Service cost $ 3 $ 3 $ 12 $ 13 Interest cost 162 171 488 518 Expected return on plan assets (133) (151) (399) (454) Amortization of prior service (benefit) cost — — (2) (2) Settlement loss 1 1 1 1 Net periodic benefit (credit) cost $ 33 $ 24 $ 100 $ 76 Other Post Employment Benefits: Service cost $ — $ 1 $ — $ 1 Interest cost 11 12 31 36 Amortization of unrecognized (gain) loss (3) (2) (9) (7) Amortization of prior service (benefit) cost (1) (1) (1) (1) Net periodic benefit (credit) cost $ 7 $ 10 $ 21 $ 29

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative [Line Items]
Fair Value of Derivatives Instruments	September 30, 2024 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Commodity contracts Other current assets $ 2 $ — $ 2 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 105 (61) 44 Commodity contracts Other current assets 3 — 3 Total asset derivatives $ 110 $ (61) $ 49 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 23 $ — $ 23 Commodity contracts Accrued and other current liabilities 1 — 1 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 64 (61) 3 Commodity contracts Accrued and other current liabilities 3 — 3 Total liability derivatives $ 91 $ (61) $ 30 December 31, 2023 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Commodity contracts Other current assets $ 3 $ — $ 3 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 83 (33) 50 Commodity contracts Other current assets 2 — 2 Total asset derivatives $ 88 $ (33) $ 55 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 23 $ — $ 23 Commodity contracts Accrued and other current liabilities 6 — 6 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 38 (33) 5 Commodity contracts Accrued and other current liabilities 8 — 8 Total liability derivatives $ 75 $ (33) $ 42 September 30, 2023 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 7 $ — $ 7 Commodity Contracts Other current assets 1 — 1 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 45 (39) 6 Total asset derivatives $ 53 $ (39) $ 14 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 7 $ — $ 7 Commodity contracts Accrued and other current liabilities 3 — 3 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 87 (39) 48 Commodity contracts Accrued and other current liabilities 3 — 3 Total liability derivatives $ 100 $ (39) $ 61
Effect of Derivatives	Amount of Gain (Loss) Recognized in OCI - Pre-Tax 1 Three Months Ended Nine Months Ended (In millions) 2024 2023 2024 2023 Derivatives designated as hedging instruments: Net investment hedges: Foreign currency contracts $ (36) $ — $ (19) $ — Cash flow hedges: Foreign currency contracts 1 11 29 (30) Commodity contracts 34 (26) (18) (133) Total derivatives designated as hedging instruments $ (1) $ (15) $ (8) $ (163) 1. OCI is defined as other comprehensive income (loss). Amount of Gain (Loss) Recognized in Income - Pre-Tax 1 Three Months Ended Nine Months Ended (In millions) 2024 2023 2024 2023 Derivatives designated as hedging instruments: Cash flow hedges: Foreign currency contracts 2 $ (2) $ (13) $ (3) $ (15) Commodity contracts 2 (10) (3) (35) 65 Total derivatives designated as hedging instruments $ (12) $ (16) $ (38) $ 50 Derivatives not designated as hedging instruments: Foreign currency contracts 3 $ 59 $ (3) $ (32) $ (65) Foreign currency contracts 2 (6) 4 12 (67) Commodity contracts 2,4 3 1 (41) 4 Commodity contracts 3 1 5 (2) 5 Total derivatives not designated as hedging instruments $ 57 $ 7 $ (63) $ (123) Total derivatives $ 45 $ (9) $ (101) $ (73) 1. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. 2. Recorded in cost of goods sold in the interim Consolidated Statements of Operations. 3. Recognized in other income (expense). Note that net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information. 4. The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the interim Consolidated Statements of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities.
Commodity Contract [Member]
Derivative [Line Items]
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Beginning balance $ (92) $ (71) $ (71) $ 55 Additions and revaluations of derivatives designated as cash flow hedges 25 (20) (13) (94) Clearance of hedge results to earnings 7 2 24 (50) Ending balance $ (60) $ (89) $ (60) $ (89)
Foreign Currency Contract [Member]
Derivative [Line Items]
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Beginning balance $ 20 $ (16) $ 1 $ 10 Additions and revaluations of derivatives designated as cash flow hedges — 7 19 (20) Clearance of hedge results to earnings 1 9 1 10 Ending balance $ 21 $ — $ 21 $ —

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities Measured on Recurring Basis	September 30, 2024 December 31, 2023 September 30, 2023 (In millions) Level 2 1 Level 2 1 Level 2 1 Assets at fair value: Marketable securities $ 56 $ 98 $ 108 Debt securities: Foreign government bonds 2 106 — — Derivatives relating to: 3 Foreign currency 105 83 52 Commodity contracts 5 5 1 Total assets at fair value $ 272 $ 186 $ 161 Liabilities at fair value: Derivatives relating to: 3 Foreign currency $ 87 $ 61 $ 94 Commodity contracts 4 14 6 Total liabilities at fair value $ 91 $ 75 $ 100 1. Reflects significant other observable inputs. 2. Represents the company's investments in debt securities that are classified as available-for-sale, which are included in marketable securities and other assets in the interim Consolidated Balance Sheets. 3. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting Information [Line Items]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	As of and for the Three Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 691 $ 1,635 $ 2,326 Segment operating EBITDA (320) 246 (74) Segment assets 1 22,192 14,895 37,087 2023 Net sales $ 878 $ 1,712 $ 2,590 Segment operating EBITDA (138) 184 46 Segment assets 1 22,829 15,446 38,275 1. Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively. As of and for the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 7,773 $ 5,157 $ 12,930 Segment operating EBITDA 2,126 811 2,937 2023 Net sales $ 7,837 $ 5,682 $ 13,519 Segment operating EBITDA 1,972 1,107 3,079
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Segment assets to total assets (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Total segment assets $ 37,087 $ 37,736 $ 38,275 Corporate assets 4,821 5,260 4,835 Total assets $ 41,908 $ 42,996 $ 43,110
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (519) $ (315) $ 913 $ 1,172 Provision for (benefit from) income taxes on continuing operations (114) (129) 274 244 Income (loss) from continuing operations before income taxes $ (633) $ (444) $ 1,187 $ 1,416 Depreciation and amortization 306 306 925 899 Interest income (33) (59) (93) (153) Interest expense 66 58 173 171 Exchange (gains) losses 97 102 234 242 Non-operating (benefits) costs 50 28 132 115 Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 14 (44) (4) 34 Significant items (benefit) charge 33 71 297 271 Corporate expenses 26 28 86 84 Segment operating EBITDA $ (74) $ 46 $ 2,937 $ 3,079

EIDP Segment FN (Tables)

EIDP Segment FN (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA Three Months Ended September 30, Nine Months Ended September 30, (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (519) $ (315) $ 913 $ 1,172 Provision for (benefit from) income taxes on continuing operations (114) (129) 274 244 Income (loss) from continuing operations before income taxes $ (633) $ (444) $ 1,187 $ 1,416 Depreciation and amortization 306 306 925 899 Interest income (33) (59) (93) (153) Interest expense 66 58 173 171 Exchange (gains) losses 97 102 234 242 Non-operating (benefits) costs 50 28 132 115 Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 14 (44) (4) 34 Significant items (benefit) charge 33 71 297 271 Corporate expenses 26 28 86 84 Segment operating EBITDA $ (74) $ 46 $ 2,937 $ 3,079
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Segment assets to total assets (In millions) September 30, 2024 December 31, 2023 September 30, 2023 Total segment assets $ 37,087 $ 37,736 $ 38,275 Corporate assets 4,821 5,260 4,835 Total assets $ 41,908 $ 42,996 $ 43,110
EIDP
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Income (loss) from continuing operations after income taxes to segment operating EBITDA Three Months Ended Nine Months Ended (In millions) 2024 2023 2024 2023 Income (loss) from continuing operations after income taxes $ (505) $ (317) $ 942 $ 1,155 Provision for (benefit from) income taxes on continuing operations (110) (129) 283 239 Income (loss) from continuing operations before income taxes $ (615) $ (446) $ 1,225 $ 1,394 Depreciation and amortization 306 306 925 899 Interest income (51) (59) (131) (153) Interest expense 66 60 173 193 Exchange (gains) losses 97 102 234 242 Non-operating (benefits) costs 50 28 132 115 Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 14 (44) (4) 34 Significant items (benefit) charge 33 71 297 271 Corporate expenses 26 28 86 84 Segment operating EBITDA $ (74) $ 46 $ 2,937 $ 3,079

Summary of Significant Accoun_3

Summary of Significant Accounting Policies Summary of Accounting Policies (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Percentage deterioration of the official Peso to USD exchange rate	10%
Percentage of annual net sales	4%
Foreign government bonds	$ 125
Percentage of Crop Protection and Seed Segment Operating EBITDA	4%

Business Combinations and Ass_2

Business Combinations and Asset Acquisitions (Details)- Purchase Price Allocation $ in Millions	12 Months Ended
	Feb. 29, 2024 USD ($)
Stoller
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 1,220
Symborg
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 370

Revenue Narrative (Details)

Revenue Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 140	$ 134	$ 135
Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 years

Revenue Contract Balances (Deta

Revenue Contract Balances (Details) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Accounts and notes receivable - trade	[1]	$ 5,501	$ 5,320	$ 4,329
Contract assets - current	[2]	29	27	27
Contract assets - noncurrent	[3]	73	67	67
Deferred Revenue		429	552	3,406
Deferred revenue recognized during the period		3,314	3,287
Other noncurrent obligations
Disaggregation of Revenue [Line Items]
Deferred Revenue	[4]	$ 115	$ 109	$ 108
[1] Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. Included in other current assets in the interim Consolidated Balance Sheets. Included in other assets in the interim Consolidated Balance Sheets. Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue Disaggregation of Reven

Revenue Disaggregation of Revenue - Principal Product Groups (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Net Sales	$ 2,326	$ 2,590	$ 12,930	$ 13,519
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales	691	878	7,773	7,837
Seed [Member] | Corn [Member]
Disaggregation of Revenue [Line Items]
Net Sales	315	487	5,085	5,139
Seed [Member] | Soybean [Member]
Disaggregation of Revenue [Line Items]
Net Sales	164	189	1,773	1,713
Seed [Member] | Other oilseeds [Member]
Disaggregation of Revenue [Line Items]
Net Sales	135	142	566	637
Seed [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	77	60	349	348
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,635	1,712	5,157	5,682
Crop Protection [Member] | Herbicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	736	815	2,568	3,043
Crop Protection [Member] | Insecticides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	437	416	1,225	1,156
Crop Protection [Member] | Fungicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	216	226	761	837
Crop Protection [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 246	$ 255	$ 603	$ 646

Revenue Disaggregation of Rev_2

Revenue Disaggregation of Revenue - Geography (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Net Sales		$ 2,326	$ 2,590	$ 12,930	$ 13,519
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales		691	878	7,773	7,837
Seed [Member] | North America
Disaggregation of Revenue [Line Items]
Net Sales	[1]	170	173	5,394	5,192
Seed [Member] | EMEA
Disaggregation of Revenue [Line Items]
Net Sales	[2]	196	198	1,365	1,441
Seed [Member] | Latin America
Disaggregation of Revenue [Line Items]
Net Sales		218	380	696	847
Seed [Member] | Asia Pacific
Disaggregation of Revenue [Line Items]
Net Sales		107	127	318	357
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales		1,635	1,712	5,157	5,682
Crop Protection [Member] | North America
Disaggregation of Revenue [Line Items]
Net Sales	[1]	440	399	1,703	1,901
Crop Protection [Member] | EMEA
Disaggregation of Revenue [Line Items]
Net Sales	[2]	219	271	1,311	1,555
Crop Protection [Member] | Latin America
Disaggregation of Revenue [Line Items]
Net Sales		771	844	1,458	1,537
Crop Protection [Member] | Asia Pacific
Disaggregation of Revenue [Line Items]
Net Sales		$ 205	$ 198	$ 685	$ 689
[1] Represents U.S. & Canada. Europe, Middle East and Africa ("EMEA").

Restructuring and Asset Relat_3

Restructuring and Asset Related Charges Asset Impairments (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Other Asset Related [Member]
Restructuring Cost and Reserve [Line Items]
Non-cash accelerated prepaid royalty amortization Charges (Benefits)	$ (2)	$ (55)	$ (66)

Restructuring and Asset Relat_4

Restructuring and Asset Related Charges 2022 Restructuring Actions (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 32	$ 2	$ 199	$ 95
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Anticipated Cash Payments		36		36
Restructuring and Related Cost, Incurred Cost	[1],[2]	3	1	1	19
2022 Restructuring Actions | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		0	0	0	4	[3]
2022 Restructuring Actions | Asset Related Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		0	0	(2)	11
2022 Restructuring Actions | Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	[2]	$ 3	1	3	4
Seed [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost			1	$ (2)	10
Crop Protection [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost			$ 0		$ 5
[1] The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment. This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information. Reflects corporate-related charges.

Restructuring and Asset Relat_5

Restructuring and Asset Related Charges - Crop Protection Operations Strategy (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended			11 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023		Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 32	$ 2	$ 199	$ 95
Crop Protection Strategy Operations Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				0
Restructuring and Related Cost, Incurred Cost		29		143
Payments for Restructuring				(7)			$ (10)
Asset write-offs				(79)
Restructuring Reserve, Ending Balance		57		57			57
Restructuring and Related Cost, Cost Incurred to Date		372		372			372
Crop Protection Strategy Operations Program [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		650		650			650
Anticipated Cash Payments		330		330			330
Crop Protection Strategy Operations Program [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		700		700			700
Anticipated Cash Payments		360		360			360
Crop Protection Strategy Operations Program [Member] | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				0
Restructuring and Related Cost, Incurred Cost	[1]	19		60
Payments for Restructuring				(3)
Asset write-offs				0
Restructuring Reserve, Ending Balance		57		57			57
Restructuring and Related Cost, Cost Incurred to Date		60		60			60
Crop Protection Strategy Operations Program [Member] | Severance and Related Benefit Costs | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		85		85			85
Crop Protection Strategy Operations Program [Member] | Severance and Related Benefit Costs | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		105		105			105
Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				0
Restructuring and Related Cost, Incurred Cost	[2],[3]	10		83
Payments for Restructuring				(4)
Asset write-offs				(79)
Restructuring Reserve, Ending Balance		0		0			0
Restructuring and Related Cost, Cost Incurred to Date		309		309			309
Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		320		320			320
Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		340		340			340
Crop Protection Strategy Operations Program [Member] | Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		3		3			3
Crop Protection Strategy Operations Program [Member] | Contract Termination | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		245		245			245
Crop Protection Strategy Operations Program [Member] | Contract Termination | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		255		255			255
Crop Protection Strategy Operations Program [Member] | Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		4		4
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Anticipated Cash Payments		36		36			$ 36
Restructuring and Related Cost, Incurred Cost	[4],[5]	3	1	1	19
2022 Restructuring Actions | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		0	0	0	4	[6]
2022 Restructuring Actions | Asset Related Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		0	0	(2)	11
2022 Restructuring Actions | Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	[5]	$ 3	1	3	4
2022 Restructuring Actions | Crop Protection [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost			0		5
2022 Restructuring Actions | Seed [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost			$ 1	$ (2)	$ 10
[1] Reflects corporate-related charges. Reflects charges associated with the Crop Protection segment. The three and nine months ended September 30, 2024 include charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California. The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment. This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information. Reflects corporate-related charges.

Supplementary Information Other

Supplementary Information Other Income (Expense) - Net (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest income		$ 33	$ 59	$ 93	$ 153
Equity in earnings (losses) of affiliates - net		0	(2)	7	4
Net gain (loss) on sales of businesses and other assets		0	10	17	11
Net exchange gains (losses)	[1]	(97)	(102)	(234)	(242)
Non-operating pension and other post employment benefit credit	[2]	(37)	(30)	(109)	(91)
Miscellaneous expenses - net	[3]	(6)	(84)	(93)	(189)
Other income - net		(107)	(149)	(319)	(354)
Hedging Program [Member]
Net exchange gains (losses)		59	2	(35)	(60)
Hedging Program [Member] | Argentine Peso Devaluation [Member]
Net exchange gains (losses)		$ (26)	$ (83)	$ (54)	$ (150)
[1] Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). The three and nine months ended September 30, 2024 includes tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont ("Tax Indemnification Adjustments"), while the nine months ended September 30, 2024 additionally includes the receipt of an indemnification payment negotiated with the prior Stoller owners and estimated settlement reserves. The three and nine months ended September 30, 2023 includes Tax Indemnification Adjustments and an adjustment to the Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) due to a change in estimate as well as estimated settlement reserves. The nine months ended September 30, 2023 also includes gains on the sale of assets, and a loss on the sale of the company's interest in an equity investment.

Supplementary Information Forei

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net	[1]	$ (97)	$ (102)	$ (234)	$ (242)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		(7)	15	30	39
Foreign Currency Transaction (Loss) Gain After Tax		(104)	(87)	(204)	(203)
Corteva [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction (Loss) Gain After Tax		(104)	(87)	(203)	(203)
EIDP
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction (Loss) Gain After Tax		0	0	1	0
Subsidiary Monetary Position
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net		(156)	(104)	(199)	(182)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		5	19	23	27
Foreign Currency Transaction (Loss) Gain After Tax		(151)	(85)	(176)	(155)
Hedging Program [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net		59	2	(35)	(60)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		(12)	(4)	7	12
Foreign Currency Transaction (Loss) Gain After Tax		$ 47	$ (2)	$ (28)	$ (48)
[1] Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.

Supplementary Information Recon

Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)	Sep. 30, 2024		Dec. 31, 2023	Sep. 30, 2023		Sep. 01, 2023	Dec. 31, 2022
Restricted Cash and Cash Equivalents Items [Line Items]
Cash and cash equivalents	$ 2,421,000,000		$ 2,644,000,000	$ 2,254,000,000
Restricted Cash	335,000,000		514,000,000	522,000,000		$ 1.185
Total Cash, Cash Equivalents and Restricted Cash Equivalents	$ 2,756,000,000	[1]	$ 3,158,000,000	$ 2,776,000,000	[1]		$ 3,618,000,000
[1]See page 15 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Supplementary Information Suppl

Supplementary Information Supplementary Information (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Accounts payable	$ 3,753	$ 4,280	$ 3,678
Accounts Payable, Trade, Current	2,051	2,952	2,046
Seed Grower Compensation
Accounts Payable, Trade, Current	$ 214	$ 560	$ 217

Income Taxes Income Tax Narrati

Income Taxes Income Tax Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	18%	29.10%	23.10%	17.20%
Net Tax Benefits	$ 10	$ 11	$ 25	$ 79
Repurchase of Common Stock			$ 757	$ 585
Effective Income Tax Rate	18%	29.10%	23.10%	17.20%
EIDP
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	17.90%	28.90%	23.10%	17.10%
Effective Income Tax Rate	17.90%	28.90%	23.10%	17.10%

Earnings Per Share Net Income f

Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Income (loss) from continuing operations after income taxes	$ (519)	$ (315)	$ 913	$ 1,172
Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations	3	3	10	10
Net income (loss) from Continuing Operations Available to Common Shareholders	(522)	(318)	903	1,162
Income (loss) from discontinued operations after income taxes	(2)	(3)	45	(174)
Basic earnings (loss) per share of common stock	$ (524)	$ (321)	$ 948	$ 988

Earnings Per Share Earnings Per

Earnings Per Share Earnings Per Share Calculations - Basic (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Basic earnings (loss) per share of common stock from continuing operations	$ (0.76)	$ (0.45)	$ 1.30	$ 1.64
Basic earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Basic earnings (loss) per share of common stock	$ (0.76)	$ (0.45)	$ 1.36	$ 1.40

Earnings Per Share Earnings P_2

Earnings Per Share Earnings Per Share Calculations - Diluted (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Diluted earnings (loss) per share of common stock from continuing operations	$ (0.76)	$ (0.45)	$ 1.29	$ 1.63
Diluted earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Diluted earnings (loss) per share of common stock	$ (0.76)	$ (0.45)	$ 1.35	$ 1.39

Earnings Per Share Share Count

Earnings Per Share Share Count Information (Details) - shares shares in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Weighted Average Common Shares - basic		691.1	708.4	695.8	710.7
Dilutive effect of equity compensation plans	[1]	0	0	2.5	2.9
Weighted Average Common Shares - diluted		691.1	708.4	698.3	713.6
Potential shares of common stock excluded from EPS calculations	[2]	2.5	2.2	3.4	2.4
[1] Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable_3

Accounts and Notes Receivable (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable - trade	[1]	$ 4,260	$ 4,013	$ 4,260	$ 4,013	$ 4,210
Notes receivable - trade	[1],[2]	1,241	1,307	1,241	1,307	119
Other	[3]	1,150	1,261	1,150	1,261	1,159
Accounts and notes receivable - net		6,651	6,581	6,651	6,581	5,488
Accounts Receivable, Allowance for Credit Loss, Current		188	201	188	201	205	$ 194
Amounts due from nonconsolidated affiliates		$ 145	137	$ 145	137	131
Other Receivable, Total Current Assets, Percentage		5%		5%
Factoring Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Trade Receivables Sold		$ 51	57	$ 118	100
Trade receivables sold the remain outstanding with an element of recourse		17	19	17	19	$ 2
Loss on Sale of Accounts Receivable		$ 5	$ 4	$ 8	$ 17
[1] Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2024, December 31, 2023 and September 30, 2023, there were no significant impairments related to current loan agreements. Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $145 million, $131 million and $137 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

Accounts and Notes Receivable A

Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Receivables [Abstract]
Accounts Receivable, Allowance for Credit Loss, Beginning Balance	$ 205	$ 194
Net Provision for Credit Losses	31	10
Write-offs charged against allowance/ other	(48)	(3)
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 188	$ 201

Inventories Schedule of Invento

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Inventory Disclosure [Abstract]
Finished Products	$ 2,399	$ 3,273	$ 2,786
Semi-finished Products	2,785	2,775	2,690
Raw Materials and Supplies	490	851	844
Total inventories	$ 5,674	$ 6,899	$ 6,320

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Goodwill [Line Items]
Goodwill, Beginning Balance	$ 10,605	$ 10,441
Goodwill, Ending Balance	$ 10,629	$ 10,605

Other Intangible Assets Other I

Other Intangible Assets Other Intangible Assets (Details) - USD ($) $ in Millions		Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 12,986	$ 13,073	$ 13,044
Finite-Lived Intangible Assets, Accumulated Amortization		(3,907)	(3,452)	(3,265)
Finite-Lived Intangible Assets, Net		9,079	9,621	9,779
Indefinite-lived Intangible Assets (Excluding Goodwill)		5	5	16
Intangible Assets, Gross (Excluding Goodwill)		12,991	13,078	13,060
Total other intangible assets		9,084	9,626	9,795
In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)		5	5	16
Germplasm [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		6,291	6,291	6,291
Finite-Lived Intangible Assets, Accumulated Amortization		(1,272)	(1,081)	(1,017)
Finite-Lived Intangible Assets, Net		5,019	5,210	5,274
Customer-Related Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		2,413	2,427	2,403
Finite-Lived Intangible Assets, Accumulated Amortization		(844)	(734)	(688)
Finite-Lived Intangible Assets, Net		1,569	1,693	1,715
Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,838	1,849	1,845
Finite-Lived Intangible Assets, Accumulated Amortization		(1,126)	(1,004)	(958)
Finite-Lived Intangible Assets, Net		712	845	887
Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		2,056	2,111	2,110
Finite-Lived Intangible Assets, Accumulated Amortization		(359)	(339)	(314)
Finite-Lived Intangible Assets, Net		1,697	1,772	1,796
Other Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[1]	388	395	395
Finite-Lived Intangible Assets, Accumulated Amortization	[1]	(306)	(294)	(288)
Finite-Lived Intangible Assets, Net	[1]	$ 82	$ 101	$ 107
[1] Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Other Intangible Assets Future

Other Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 170	$ 174	$ 521	$ 508
Continuing Operations [Member]
Finite-Lived Intangible Assets [Line Items]
Pre-tax amortization expense, remainder of 2024	164		164
Pre-tax amortization expense, 2025	644		644
Pre-tax amortization expense, 2026	634		634
Pre-tax amortization expense, 2027	574		574
Pre-tax amortization expense, 2028	552		552
Pre-tax amortization expense, 2029	$ 529		$ 529

Short-Term Borrowings, Long-T_3

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Short-term Debt [Line Items]
Long-term Debt Payable within one year	$ 500	$ 196	$ 188
Finance Lease, Liability, Current	1	1	1
Short-term borrowings and finance lease obligations	3,741	198	3,609
Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term borrowings	2,969	0	3,417
Other loans - various currencies [Member]
Short-term Debt [Line Items]
Short-term borrowings	271	1	3
364-day Revolving Credit Facilities due 2023 | Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings	$ 0	$ 0	$ 0

Short-Term Borrowings, Long-T_4

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Feb. 20, 2024	Dec. 31, 2023	Sep. 30, 2023	May 01, 2023	Feb. 01, 2023
Debt Instrument [Line Items]
Long-term Debt Payable within one year	$ 500		$ 196	$ 188
Long-term Debt and Lease Obligation	1,975		2,291	2,290
Finance Lease, Liability, Noncurrent	0		1	1
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	13		16	17
Line of Credit Facility, Maximum Borrowing Capacity	5,750
Line of Credit Facility, Remaining Borrowing Capacity	5,750
EIDP
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	1,975		2,291	2,290
Foreign Currency Loans
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	38
Revolving Credit Facilities due 2027
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,900
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,900
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2027 | EIDP
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,000
Debt Instrument, Term	5 years
Revolving Credit Facilities due 2025 [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000
Debt Instrument, Term	3 years
364-day Revolving Credit Facilities due 2023
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 1,000	$ 1,000
Revolving Credit Facilities due 2029
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,850
Line of Credit Facility, Remaining Borrowing Capacity	$ 2,850
Debt Instrument, Term	5 years
364-day Revolving Credit Facilities due 2025
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000	$ 1,000
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,000
Debt Instrument, Term	364 days
Medium-term Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 104		$ 106	$ 106
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.94%		5.34%	5.33%
Loans Payable [Member] | Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 184		$ 196	$ 188
Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	12.70%		14.80%	14.80%
Senior Notes | Notes Maturing 2025 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500		$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	1.70%		1.70%	1.70%
Senior Notes | Notes Maturing 2026 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 600		$ 600	$ 600
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.50%		4.50%	4.50%
Senior Notes | Notes Maturing 2030 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500		$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	2.30%		2.30%	2.30%
Senior Notes | Notes Maturing 2033 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 600		$ 600	$ 600
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.80%		4.80%	4.80%
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 2,437		$ 2,434	$ 2,320

Short-Term Borrowings, Long-T_5

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Feb. 20, 2024 USD ($)	Dec. 31, 2023 USD ($)	May 01, 2023 USD ($)	Feb. 01, 2023 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 5,750
Line of Credit Facility, Maximum Borrowing Capacity	5,750
Proceeds from debt	3,047	$ 3,427
Repayments of Long-term Debt	1,529	1,314
EIDP
Line of Credit Facility [Line Items]
Proceeds from debt	3,047	3,427
Repayments of Long-term Debt	1,529	1,314
Foreign Currency Loans
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	38
Revolving Credit Facilities due 2025 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2025 [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR	0.10%
Revolving Credit Facilities due 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,900
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,900
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2027 | EIDP
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,000
Debt Instrument, Term	5 years
Revolving Credit Facility
Line of Credit Facility [Line Items]
Ratio of Indebtedness to Net Capital	0.60
364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 1,000	$ 1,000
Ratio of Indebtedness to Net Capital	0.60
364-day Revolving Credit Facilities due 2023 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR	0.10%
364-day Revolving Credit Facilities due 2025
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000		$ 1,000
Debt Instrument, Term	364 days
Securities Sold under Agreements to Repurchase [Member] | 364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Short-term borrowings	$ 0	$ 0		$ 0

Commitments and Contingent Li_3

Commitments and Contingent Liabilities - Supplier Finance (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Supplier Finance Program, Obligation, Current	$ 124	$ 115	$ 115
Supplier Finance Program, Obligation [Roll Forward]
Invoices confirmed during the year (Supplier Finance Program, Obligation, Addition)	460
Confirmed invoices paid during the year (Supplier Finance Program, Obligation, Settlement)	$ 451

Commitments and Contingent Li_4

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 75	$ 84	$ 73
Greater than one year
Guarantor Obligations [Line Items]
Guarantee Obligations	15
Factoring Agreement [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	4	2	4
Agreements with lenders to provide financing for select customers [Member]
Guarantor Obligations [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 598	$ 187	$ 492

Commitments and Contingent Li_5

Commitments and Contingent Liabilities Chemours (Details) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2017 USD ($) lawsuits	Sep. 30, 2024 USD ($)	Dec. 31, 2028 USD ($)
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 670
Lawsuits alleging personal injury filed | lawsuits	3,550
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage		29%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS		$ 200
Stray liability sharing percentage		71%
PFAS [Member]
Loss Contingencies [Line Items]
Minimum Settlement Amount Required To Allow Withdrawals From Escrow Account		$ 125
Threshold to waive MOU escrow account funding obligation		$ 100
PFAS [Member] | Forecast [Member]
Loss Contingencies [Line Items]
Escrow Account Balance			$ 700
PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Cost Sharing Arrangement Term		20 years
Qualified Spend and Escrow Account Contribution Threshold		$ 4,000
PFAS [Member] | Chemours [Member]
Loss Contingencies [Line Items]
Escrow Account Deposit Percentage		50%
PFAS [Member] | Chemours [Member] | No later than September 30 of each subsequent year through and including 2028
Loss Contingencies [Line Items]
Escrow Balance		$ 50
PFAS [Member] | Chemours [Member] | No later than each of September 30, 2021 and September 30, 2022
Loss Contingencies [Line Items]
Escrow Balance		100
PFAS [Member] | Chemours [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Escrow Balance		$ 500
PFAS [Member] | Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS		50%
PFAS [Member] | Corteva [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold		$ 600
PFAS [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS		50%
PFAS [Member] | Corteva and DuPont
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS		50%
Escrow Account Deposit Percentage		50%
Amount credited to each company's threshold		$ 150
PFAS [Member] | Corteva and DuPont | No later than September 30 of each subsequent year through and including 2028
Loss Contingencies [Line Items]
Escrow Balance		50
PFAS [Member] | Corteva and DuPont | No later than each of September 30, 2021 and September 30, 2022
Loss Contingencies [Line Items]
Escrow Balance		100
PFAS [Member] | Corteva and DuPont | Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold		2,000
Corteva and DuPont stray liability threshold for PFAS		300
Escrow Balance		$ 500

Commitments and Contingent Li_6

Commitments and Contingent Liabilities Corteva Separation (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Accounts and Notes Receivable [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 36,000,000	$ 44,000,000	$ 36,000,000
Other Assets [Member]
Loss Contingencies [Line Items]
Indemnification Assets	129,000,000	104,000,000	126,000,000
Accrued and Other Current Liabilities [Member]
Loss Contingencies [Line Items]
Indemnified Liabilities	19,000,000	30,000,000	38,000,000
Other noncurrent obligations
Loss Contingencies [Line Items]
Indemnified Liabilities	141,000,000	$ 106,000,000	$ 108,000,000
PFAS [Member] | Minimum [Member]
Loss Contingencies [Line Items]
De minimis threshold	1,000,000
Corteva and DuPont stray liability threshold for PFAS	1
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Stray liability sharing percentage	29%
Corteva [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71%
Corteva and DuPont stray liability threshold for PFAS	$ 200,000,000
DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000

Commitments and Contingent Li_7

Commitments and Contingent Liabilities- DISCOPs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Loss Contingencies [Line Items]
Income (loss) from discontinued operations after income taxes	$ (2)	$ (3)	$ 45	$ (174)

Commitments and Contingent Li_8

Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)		3 Months Ended		9 Months Ended	12 Months Ended
	Jan. 31, 2021 USD ($)	Mar. 31, 2021 lawsuits	Jun. 30, 2017 USD ($) lawsuits	Sep. 30, 2024 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2004 USD ($)	Jan. 01, 2012
MDL Settlement [Domain]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 83,000,000
DuPont de Nemours and Corteva Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 27,000,000
Payments for Legal Settlements					$ 27,000,000
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size						80,000
Loss Contingency, Number Of Water Districts Receiving Water Treatment							6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold						$ 235,000,000
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date				$ 2,000,000
Escrow Balance				$ 1,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Settled Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Settled, Number | lawsuits		95
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Disease Categories for MDL							6
Lawsuits alleging personal injury filed | lawsuits			3,550
Litigation Settlement, Amount Awarded to Other Party			$ 670,000,000

Commitments and Contingent Li_9

Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) $ in Millions		3 Months Ended	9 Months Ended	12 Months Ended
	Jan. 31, 2021 USD ($)	Jun. 30, 2017 USD ($)	Sep. 30, 2024 USD ($) lawsuits	Dec. 31, 2023 USD ($)
Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits			4,500
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 670
Chemours Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 29
NEW JERSEY | Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number			2
OHIO | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits			2
Litigation Settlement, Amount Awarded to Other Party				$ 110
OHIO | Corteva Contribution to Ohio NRD Settlement | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party			$ 16
NORTH CAROLINA | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Property Owners			2,400
DELAWARE | Natural Resources Damages [Member] | Corteva [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Threshold for payments to fund the NRST Trust			$ 50
Supplemental payment threshold			$ 25
Period for supplemental payment			8 years
Estimated Litigation Liability			$ 4
Alabama Water Utility [Member] | Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number			1

Commitments and Contingent L_10

Commitments and Contingent Liabilities Environmental (Details) - USD ($) $ in Millions		Sep. 30, 2024	Jan. 28, 2022
Loss Contingencies [Line Items]
Indemnification Asset		$ 259
Accrual for Environmental Loss Contingencies		477
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual		644
Non-PFAS
Loss Contingencies [Line Items]
Request for Remediation Funding Source ("RFS")			$ 900
Chemours related obligation subject to indemnification [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[1],[2]	150
Accrual for Environmental Loss Contingencies	[1],[2],[3]	153
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2],[3]	277
Discontinued Operations [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[1]	34
Other discontinued or divested business obligations [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	[1],[3]	71
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[3]	203
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[2]	49
Accrual for Environmental Loss Contingencies	[2],[3]	52
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[2],[3]	61
Not subject to indemnification [Member]
Loss Contingencies [Line Items]
Indemnification Asset		0
Accrual for Environmental Loss Contingencies		105
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual		90
Indemnification liabilities related to the MOU
Loss Contingencies [Line Items]
Indemnification Asset	[4]	26
Accrual for Environmental Loss Contingencies	[3],[4]	96
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[3],[4]	13
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold		200
Superfund Sites [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies		47
Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]
Loss Contingencies [Line Items]
Indemnification Asset		$ 19
[1] Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 23, under the header "Corteva Separation Agreement." The company has recorded an indemnification asset related to these accruals, including $19 million related to the Superfund sites. Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $47 million for remediation of Superfund sites. Amounts do not include all possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 28 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ"). Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 22, under the header "Chemours Separation Agreement (Performance Chemicals)."

Stockholders' Equity Common Sto

Stockholders' Equity Common Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Sep. 13, 2022	Aug. 05, 2021	Jun. 26, 2019
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Repurchase of Common Stock			$ 757	$ 585
2021 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares					4,098,000	17,425,000	5,572,000
Stock Repurchase Program, Authorized Amount									$ 1,500
Repurchase of Common Stock					$ 250	$ 1,000	$ 250
2022 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares	4,722,000	4,913,000	13,838,000	6,330,000
Stock Repurchase Program, Authorized Amount								$ 2,000
Repurchase of Common Stock	$ 250	$ 250	$ 750	$ 330
Corteva [Member]
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01		$ 0.01							$ 0.01

Stockholders' Equity Preferred

Stockholders' Equity Preferred Stock (Details) - EIDP - USD ($)	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
$4.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 4.50
$3.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 3.50
Corteva [Member]
Class of Stock [Line Items]
Ownership interest in an entity	100%

Stockholders' Equity Other Comp

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		3 Months Ended						9 Months Ended
		Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				$ (2,677)				$ (2,677)
Beginning Balance		$ 25,421	$ 25,008	25,279	$ 26,461	$ 25,839	$ 25,541	25,279	$ 25,541
Amounts Reclassified from Accumulated Other Comprehensive Loss		5			10			17	(46)
Other comprehensive (loss) income		438	(314)	(333)	(324)	62	67	(209)	(195)
Ending Balance		24,979	25,421	25,008	25,467	26,461	25,839	24,979	25,467
Ending Balance		(2,886)			(3,001)			(2,886)	(3,001)
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				(353)			(163)	(353)	(163)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax								2	6
Amounts Reclassified from Accumulated Other Comprehensive Loss								(1)	0
Other comprehensive (loss) income								1	6
Ending Balance		(352)			(157)			(352)	(157)
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				189			160	189	160
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax								0	0
Amounts Reclassified from Accumulated Other Comprehensive Loss								(7)	(6)
Other comprehensive (loss) income								(7)	(6)
Ending Balance		182			154			182	154
Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				(2,458)			(2,883)	(2,458)	(2,883)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax	[1]							(206)	(41)
Amounts Reclassified from Accumulated Other Comprehensive Loss								0	0
Other comprehensive (loss) income								(206)	(41)
Ending Balance		(2,664)			(2,924)			(2,664)	(2,924)
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				(55)			80	(55)	80
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax								(8)	(114)
Amounts Reclassified from Accumulated Other Comprehensive Loss		8			11			25	(40)
Other comprehensive (loss) income								17	(154)
Ending Balance		(38)			(74)			(38)	(74)
Unrealized Gain (loss) on Investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				0			0	0	0
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax								(14)	0
Amounts Reclassified from Accumulated Other Comprehensive Loss								0	0
Other comprehensive (loss) income								(14)	0
Ending Balance		(14)			0			(14)	0
Total
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance				(2,677)			(2,806)	(2,677)	(2,806)
Beginning Balance		(3,324)	(3,010)	(2,677)	(2,677)	(2,739)	(2,806)	(2,677)	(2,806)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax								(226)	(149)
Amounts Reclassified from Accumulated Other Comprehensive Loss								17	(46)
Other comprehensive (loss) income		438	(314)	(333)	(324)	62	67	(209)	(195)
Ending Balance		(2,886)	$ (3,324)	$ (3,010)	(3,001)	$ (2,677)	$ (2,739)	(2,886)	(3,001)
Ending Balance		$ (2,886)			$ (3,001)			$ (2,886)	$ (3,001)
[1] The cumulative translation adjustment loss for the nine months ended September 30, 2024 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and Mexican Peso ("MXN"). The cumulative translation adjustment loss for the nine months ended September 30, 2023 was primarily driven by the strengthening of the USD against the South African Rand ("ZAR") and Euro ("EUR"), partially offset by the weakening of the USD against the Brazilian Real (BRL).

Stockholders' Equity Tax Benefi

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (3)	$ (2)	$ (10)	$ 61
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	0	0	0	0
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	1	1	3	2
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (4)	$ (3)	$ (13)	$ 59

Stockholders' Equity Reclassifi

Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss		$ 5	$ 10	$ 17	$ (46)
Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss				(1)	0
Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss				(7)	(6)
Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[1]	12	16	38	(50)
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax	[2]	(4)	(5)	(13)	10
Amounts Reclassified from Accumulated Other Comprehensive Loss		8	11	25	(40)
Actuarial (Gains) Losses | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	(3)	(2)	(9)	(7)
Settlement Loss | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	1	1	1	1
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		0	1	(1)	(1)
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax	[2]	(1)	0	0	1
Amounts Reclassified from Accumulated Other Comprehensive Loss		(1)	1	(1)	0
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		(3)	(3)	(10)	(8)
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax	[2]	1	1	3	2
Amounts Reclassified from Accumulated Other Comprehensive Loss		(2)	(2)	(7)	(6)
Unrealized loss on investments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss				0	0
Prior Service Benefit | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	0	(1)	(1)	(1)
Prior Service Benefit | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	$ (1)	$ 0	$ (2)	$ (2)
[1] Reflected in cost of goods sold in the interim Consolidated Statements of Operations. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, to the interim Consolidated Financial Statements, for additional information.

Pension Plans and Other Post _3

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	$ 3	$ 3	$ 12	$ 13
Interest Cost	162	171	488	518
Expected return on plan assets	(133)	(151)	(399)	(454)
Amortization of Prior Service Benefit	0	0	(2)	(2)
Settlement Loss (Gain)	1	1	1	1
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	33	24	100	76
Other Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	0	1	0	1
Interest Cost	11	12	31	36
Amortization of unrecognized loss (gain)	(3)	(2)	(9)	(7)
Amortization of Prior Service Benefit	(1)	(1)	(1)	(1)
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	$ 7	$ 10	$ 21	$ 29

Financial Instruments Financial

Financial Instruments Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Debt Securities, Available-for-sale [Line Items]
Fair Value, Within One Year	$ 16
Fair Value, one to five years	90
Cash Equivalents [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	1,543	$ 1,746	$ 1,619
Marketable Securities [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 56	98	$ 108
Other Assets [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities		$ 55

Financial Instruments Notional

Financial Instruments Notional Amounts (Details) € in Millions, $ in Millions	Sep. 30, 2024 USD ($)	Jul. 31, 2024 EUR (€)	May 31, 2024 EUR (€)	Feb. 29, 2024 EUR (€)	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2020 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount | $	$ 1,305				$ 1,600	$ 2,199
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount | €		€ 500	€ 500	€ 1,200			€ 450

Financial Instruments Cash Flow

Financial Instruments Cash Flow Hedges Included in AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 1,305	$ 2,199	$ 1,305	$ 2,199	$ 1,600
Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity	2 years		2 years
Beginning Balance	$ (92)	(71)	$ (71)	55
Additions and revaluations of derivatives designated as cash flow hedges	25	(20)	(13)	(94)
Clearance of hedge results to earnings	7	2	24	(50)
Ending Balance	$ (60)	(89)	(60)	(89)
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			$ 70
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity	2 years		2 years
Beginning Balance	$ 20	(16)	$ 1	10
Additions and revaluations of derivatives designated as cash flow hedges	0	7	19	(20)
Clearance of hedge results to earnings	1	9	1	10
Ending Balance	$ 21	$ 0	21	$ 0
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			$ 21

Financial Instruments Fair Valu

Financial Instruments Fair Value of Derivatives (Details) - USD ($) $ in Millions		Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		Other current assets	Other current assets	Other current assets
Derivative Asset, Gross		$ 110	$ 88	$ 53
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	(61)	(33)	(39)
Derivative Asset, Net		$ 49	$ 55	$ 14
Derivative Liability, Statement of Financial Position [Extensible Enumeration]		Accrued and other current liabilities	Accrued and other current liabilities	Accrued and other current liabilities
Derivative Liability, Gross		$ 91	$ 75	$ 100
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	(61)	(33)	(39)
Derivative Liability, Net		30	42	61
Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross				7
Derivative Asset, Counterparty and Cash Collateral Netting	[1]			0
Derivative Asset, Net				7
Derivative Liability, Gross		23	23	7
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	0	0	0
Derivative Liability, Net		23	23	7
Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		105	83	45
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	(61)	(33)	(39)
Derivative Asset, Net		44	50	6
Derivative Liability, Gross		64	38	87
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	(61)	(33)	(39)
Derivative Liability, Net		3	5	48
Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		2	3	1
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	0	0	0
Derivative Asset, Net		2	3	1
Derivative Liability, Gross		1	6	3
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	0	0	0
Derivative Liability, Net		1	6	3
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		3	2
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	0	0
Derivative Asset, Net		3	2
Derivative Liability, Gross		3	8	3
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	0	0	0
Derivative Liability, Net		$ 3	$ 8	$ 3
[1]Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Financial Instruments Effect of

Financial Instruments Effect of Derivative Instruments (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Cost of Goods Sold	Cost of Goods Sold	Cost of Goods Sold	Cost of Goods Sold
Gain (Loss) on Derivative Instruments, Net, Pretax		$ 45	$ (9)	$ (101)	$ (73)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax		(1)	(15)	(8)	(163)
Amount of gain (loss) recognized in Income - Pre-tax	[1]	(12)	(16)	(38)	50
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax		(36)	0	(19)	0
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax		1	11	29	(30)
Amount of gain (loss) recognized in Income - Pre-tax	[1],[2]	(2)	(13)	(3)	(15)
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax		34	(26)	(18)	(133)
Amount of gain (loss) recognized in Income - Pre-tax	[1],[2]	(10)	(3)	(35)	65
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax		57	7	(63)	(123)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[2]	(6)	4	12	(67)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income - net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[3]	59	(3)	(32)	(65)
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[2],[4]	3	1	(41)	4
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Income - net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[3]	$ 1	$ 5	$ (2)	$ 5
[1] For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. Recorded in cost of goods sold in the interim Consolidated Statements of Operations. The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the interim Consolidated Statements of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities.

Financial Instruments (Details)

Financial Instruments (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)
Schedule of Held-to-maturity Securities [Line Items]
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current	$ 55	$ 55
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-Sale, Unrealized Gain (Loss)	(13)	(1)
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	103	103
Amortized Cost, Within One Year	17	17
Fair Value, Within One Year	16	16
Fair Value, one to five years	$ 90	$ 90

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions		Sep. 30, 2024		Dec. 31, 2023		Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset		$ 110		$ 88		$ 53
Derivative Liability		91		75		100
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	[1]	56		98		108
Assets at Fair Value		272		186		161
Liabilities at Fair Value		91		75		100
Available - for- sale securities		106	[1],[2]	0	[2]	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Currency Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	[1],[3]	105		83		52
Derivative Liability	[1],[3]	87		61		94
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	[1],[3]	5		5		1
Derivative Liability	[1],[3]	$ 4		$ 14		$ 6
[1] Reflects significant other observable inputs. Represents the company's investments in debt securities that are classified as available-for-sale, which are included in marketable securities and other assets in the interim Consolidated Balance Sheets. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Segment Reporting Segment Infor

Segment Reporting Segment Information (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2024		Sep. 30, 2023		Sep. 30, 2024		Sep. 30, 2023		Dec. 31, 2023
Segment Reporting Information [Line Items]
Net Sales	$ 2,326		$ 2,590		$ 12,930		$ 13,519
Segment operating EBITDA	(74)		46		2,937		3,079
Total Assets	41,908		43,110		41,908		43,110		$ 42,996
Income (loss) from continuing operations after income taxes	(519)		(315)		913		1,172
Interest Expense	66		58		173		171
Income from continuing operations before income taxes	(633)		(444)		1,187		1,416
Interest income	33		59		93		153
Segments
Segment Reporting Information [Line Items]
Net Sales	2,326		2,590
Segment operating EBITDA	(74)		46
Total Assets	37,087		38,275		37,087		38,275		37,736
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Corporate Expenses	26		28		86		84
Interest income	(33)		(59)		(93)		(153)
EIDP
Segment Reporting Information [Line Items]
Net Sales	2,326		2,590		12,930		13,519
Segment operating EBITDA	(74)		46		2,937		3,079
Total Assets	43,413		43,327		43,413		43,327		43,373
Income (loss) from continuing operations after income taxes	(505)		(317)		942		1,155
Interest Expense	66		60		173		193
Income from continuing operations before income taxes	(615)		(446)		1,225		1,394
EIDP | Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Corporate Expenses	26		28		86		84
Interest income	(51)		(59)		(131)		(153)
Seed [Member]
Segment Reporting Information [Line Items]
Net Sales	691		878		7,773		7,837
Seed [Member] | Segments
Segment Reporting Information [Line Items]
Net Sales	691		878		7,773
Segment operating EBITDA	(320)		(138)		2,126		1,972
Total Assets	22,192	[1]	22,829	[1]	22,192	[1]	22,829	[1]	22,732
Crop Protection [Member]
Segment Reporting Information [Line Items]
Net Sales	1,635		1,712		5,157		5,682
Crop Protection [Member] | Segments
Segment Reporting Information [Line Items]
Net Sales	1,635
Segment operating EBITDA	246		184		811		1,107
Total Assets	$ 14,895	[1]	$ 15,446		$ 14,895	[1]	$ 15,446		$ 15,004
[1]Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively. As of and for the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2024 Net sales $ 7,773 $ 5,157 $ 12,930 Segment operating EBITDA 2,126 811 2,937 2023 Net sales $ 7,837 $ 5,682 $ 13,519 Segment operating EBITDA 1,972 1,107 3,079

Segment Reporting Segment Recon

Segment Reporting Segment Reconciliation (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Income (loss) from continuing operations after income taxes		$ (519)	$ (315)	$ 913	$ 1,172
Provision for (benefit from) income taxes on continuing operations		(114)	(129)	274	244
Income from continuing operations before income taxes		(633)	(444)	1,187	1,416
Depreciation and Amortization				925	899
Interest income		33	59	93	153
Interest Expense		66	58	173	171
Exchange (gains) losses - net	[1]	(97)	(102)	(234)	(242)
Segment operating EBITDA		(74)	46	2,937	3,079
EIDP
Segment Reporting Information [Line Items]
Income (loss) from continuing operations after income taxes		(505)	(317)	942	1,155
Provision for (benefit from) income taxes on continuing operations		(110)	(129)	283	239
Income from continuing operations before income taxes		(615)	(446)	1,225	1,394
Depreciation and Amortization				925	899
Interest Expense		66	60	173	193
Segment operating EBITDA		(74)	46	2,937	3,079
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		306	306	925	899
Interest income		(33)	(59)	(93)	(153)
Exchange (gains) losses - net		97	102	234	242
Nonoperating (benefits) costs		50	28	132	115
Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges		14	(44)	(4)	34
Significant Items (benefits) charge		(33)	(71)	(297)	(271)
Corporate Expenses		26	28	86	84
Segment Reconciling Items [Member] | EIDP
Segment Reporting Information [Line Items]
Depreciation and Amortization		306	306	925	899
Interest income		(51)	(59)	(131)	(153)
Exchange (gains) losses - net		97	102	234	242
Nonoperating (benefits) costs		50	28	132	115
Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges		14	(44)	(4)	34
Significant Items (benefits) charge		33	71	297	271
Corporate Expenses		$ 26	$ 28	$ 86	$ 84
[1] Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.

Segment Reporting Segment Asset

Segment Reporting Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total Assets	$ 41,908	$ 42,996	$ 43,110
Segments
Segment Reporting Information [Line Items]
Total Assets	37,087	37,736	38,275
Corporate
Segment Reporting Information [Line Items]
Total Assets	$ 4,821	$ 5,260	$ 4,835

Segment Reporting Significant I

Segment Reporting Significant Items (Details) - USD ($) $ in Millions		3 Months Ended			9 Months Ended
		Sep. 30, 2024		Sep. 30, 2023	Sep. 30, 2024		Sep. 30, 2023
Segment Reporting Information [Line Items]
Restructuring Charges					$ 199		$ 95
Gain (loss) on sale of assets					17		12
Net Sales		$ 2,326		$ 2,590	12,930		13,519
Seed [Member]
Segment Reporting Information [Line Items]
Net Sales		691		878	7,773		7,837
Crop Protection [Member]
Segment Reporting Information [Line Items]
Net Sales		1,635		1,712	5,157		5,682
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	[1]			(2)			(95)
Estimated Settlement Expense	[2]			(66)	(101)		(156)
Gain (Loss) on Disposition of Business	[3]			4			7
Inventory Write-down	[3]						(7)
Gain (loss) on sale of assets	[3]				7
Acquisition-related costs		(1)	[4]	(7)	(6)	[4]	(41)	[4]
Employee Retention Credit							3
Significant Items (benefits) charge		(33)		(71)	(297)		(271)
Restructuring and Asset related charges, net	[1]	(32)			(199)
Segment Reconciling Items [Member] | 2022 Restructuring Actions- Russia Exit
Segment Reporting Information [Line Items]
Inventory Write-down	[3]				2
Russia Seed Sale, pre-tax benefit	[3],[5]						18
Segment Reconciling Items [Member] | Seed [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	[1]	(3)		1	(56)		(74)
Estimated Settlement Expense				0	0	[2]	0
Gain (Loss) on Disposition of Business	[3]			4
Inventory Write-down	[3]				2		(7)
Gain (loss) on sale of assets	[3]				4		4
Acquisition-related costs		0		0	0	[4]	0
Employee Retention Credit							0
Significant Items (benefits) charge		(3)		5	(50)		(59)
Segment Reconciling Items [Member] | Seed [Member] | 2022 Restructuring Actions- Russia Exit
Segment Reporting Information [Line Items]
Russia Seed Sale, pre-tax benefit					18		18	[3],[5]
Net Sales							71
Cost of Revenue							53
Segment Reconciling Items [Member] | Crop Protection [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	[1]	(10)		0	(83)		(11)
Estimated Settlement Expense	[2]			(66)	(101)		(156)
Gain (Loss) on Disposition of Business				0			3	[3]
Inventory Write-down					0	[3]	0
Gain (loss) on sale of assets	[3]				3
Acquisition-related costs		(1)	[4]	(7)	(6)	[4]	(41)	[4]
Employee Retention Credit							3
Significant Items (benefits) charge		(11)		(73)	(187)		(202)
Segment Reconciling Items [Member] | Crop Protection [Member] | 2022 Restructuring Actions- Russia Exit
Segment Reporting Information [Line Items]
Russia Seed Sale, pre-tax benefit							0
Segment Reconciling Items [Member] | Corporate Segment
Segment Reporting Information [Line Items]
Restructuring Charges	[1]	(19)		(3)	(60)		(10)
Estimated Settlement Expense				0	0	[2]	0
Gain (Loss) on Disposition of Business				0			0
Inventory Write-down					0	[3]	0
Gain (loss) on sale of assets	[3]				0
Acquisition-related costs		0		0	0	[4]	0
Employee Retention Credit							0
Significant Items (benefits) charge		$ (19)		$ (3)	$ (60)		(10)
Segment Reconciling Items [Member] | Corporate Segment | 2022 Restructuring Actions- Russia Exit
Segment Reporting Information [Line Items]
Russia Seed Sale, pre-tax benefit							$ 0
[1] Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. Consists of estimated Lorsban® related charges. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. The nine months ended September 30, 2024 includes a $2 million benefit associated with sales of inventory previously reserved for in association with the 2022 Restructuring Actions. Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information. Includes a benefit (charge) of $18 million for the nine months ended September 30, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the nine months ended September 30, 2023.

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Subsequent Event [Line Items]
Restructuring Charges	$ 199	$ 95

EID - Basis of Presentation Nar

EID - Basis of Presentation Narrative (Details) - $ / shares	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 26, 2019
Common Stock, Shares, Outstanding	689,170,000	701,260,000	704,880,000
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
EIDP
Common Stock, Shares, Outstanding	200	200	200
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30
EIDP | $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividend Rate, Per-Dollar-Amount	4.50
EIDP | $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividend Rate, Per-Dollar-Amount	3.50
Corteva [Member]
Common Stock, Par Value	$ 0.01			$ 0.01
Corteva [Member] | EIDP
Ownership interest in an entity	100%

EIDP - Related Party Transact_2

EIDP - Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Related Party Transaction [Line Items]
Accrued and other current liabilities	$ 2,188	$ 2,273	$ 2,188	$ 2,273	$ 2,351
Other assets	1,644	1,561	1,644	1,561	1,519
EIDP
Related Party Transaction [Line Items]
Accrued and other current liabilities	2,177	2,284	2,177	2,284	2,347
Other assets	3,149	$ 1,778	3,149	$ 1,778	1,896
EIDP | Corteva [Member]
Related Party Transaction [Line Items]
Debt, Weighted Average Interest Rate		7%		7%
Interest Expense		$ 2		$ 22
Short-term borrowings	0	115	0	115	0
Other assets	1,505	217	1,505	217	377
Interest Income, Other	18		38
Accrued and Other Current Liabilities [Member] | EIDP | Corteva [Member]
Related Party Transaction [Line Items]
Accrued and other current liabilities	19	38	19	38	30
Other noncurrent obligations | EIDP | Corteva [Member]
Related Party Transaction [Line Items]
Accounts Payable and Accrued Liabilities, Noncurrent	$ 141	$ 108	$ 141	$ 108	$ 106

Income Taxes Income Tax Narra_2

Income Taxes Income Tax Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Effective Income Tax Rate	18%	29.10%	23.10%	17.20%
EIDP
Effective Income Tax Rate	17.90%	28.90%	23.10%	17.10%

EIDP Segment FN Segment reconci

EIDP Segment FN Segment reconciliation (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Income (loss) from continuing operations after income taxes		$ (519)	$ (315)	$ 913	$ 1,172
Provision for (benefit from) income taxes on continuing operations		(114)	(129)	274	244
Income from continuing operations before income taxes		(633)	(444)	1,187	1,416
Depreciation and Amortization				925	899
Interest income		33	59	93	153
Interest Expense		66	58	173	171
Exchange (gains) losses - net	[1]	(97)	(102)	(234)	(242)
Segment operating EBITDA		(74)	46	2,937	3,079
EIDP
Segment Reporting Information [Line Items]
Income (loss) from continuing operations after income taxes		(505)	(317)	942	1,155
Provision for (benefit from) income taxes on continuing operations		(110)	(129)	283	239
Income from continuing operations before income taxes		(615)	(446)	1,225	1,394
Depreciation and Amortization				925	899
Interest Expense		66	60	173	193
Segment operating EBITDA		(74)	46	2,937	3,079
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		306	306	925	899
Interest income		(33)	(59)	(93)	(153)
Exchange (gains) losses - net		97	102	234	242
Nonoperating (benefits) costs		50	28	132	115
Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges		14	(44)	(4)	34
Significant Items (benefits) charge		(33)	(71)	(297)	(271)
Corporate Expenses		26	28	86	84
Segment Reconciling Items [Member] | EIDP
Segment Reporting Information [Line Items]
Depreciation and Amortization		306	306	925	899
Interest income		(51)	(59)	(131)	(153)
Exchange (gains) losses - net		97	102	234	242
Nonoperating (benefits) costs		50	28	132	115
Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges		14	(44)	(4)	34
Significant Items (benefits) charge		33	71	297	271
Corporate Expenses		26	28	86	84
Crop Protection [Member] | Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Significant Items (benefits) charge		$ (11)	$ (73)	$ (187)	$ (202)
[1] Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.

EIDP Segment FN Segment Asset R

EIDP Segment FN Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total Assets	$ 41,908	$ 42,996	$ 43,110
EIDP
Segment Reporting Information [Line Items]
Total Assets	$ 43,413	$ 43,373	$ 43,327